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Abstract 
 
With recent advances in high-throughput sequencing, mapping of genome-wide transcription factor 
occupancy has become feasible.  To advance the understanding of skeletal muscle differentiation 
specifically and transcriptional regulation in general, I determined the genome-wide occupancy map for 
myogenin in differentiating C2C12 myocyte cells.  I then analyzed the myogenin map for underlying 
sequence content and the association between occupied elements and expression trajectories of 
adjacent genes.  Having determined that myogenin primarily associates with expressed genes, I 
performed a similar analysis on occupancy maps of other transcription factors active during skeletal 
muscle differentiation, including an extensive analysis of co-occupancy.  This analysis provided strong 
motif evidence for protein-protein interactions as the primary driving force in the formation of 
Myogenin / Mef2 and MyoD / AP-1 complexes at jointly-occupied sites.  Finally, factor occupancy 
analysis was extended to include bHLH transcription factors in tissues other than skeletal muscle.  The 
cross-tissue analysis led to the emergence of a motif structure used by bHLH TFs to encode either tissue-
specific or "general" (public) access in a variety of lineages. 
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Chapter 1:  Introduction 
 
1.1 Overview 
 
The core of this thesis will focus on the study of the transcriptional regulation of muscle differentiation.  
In mammals, this is a stepwise process in which multipotential mesodermal precursors first give rise to 
unipotential myoblasts, characterized by their ability to proliferate and migrate.  The myoblasts in turn 
differentiate into post-mitotic myocytes, at which point most of the molecular markers associated with 
muscle are expressed.  Myocytes further undergo membrane fusion and form multinucleated mytubes, 
which mature into functional myofibers, completing the process.  To facilitate the genomic study of 
myogenesis, several myoblast cell lines have been cultured over time, capable of recapitulating the 
transition with high efficiency.  One such cell line - murine C2C12s (utilized very commonly in the field) - 
was used as a model for my experimental work.  A key characteristic of the C2C12 cells  is that they are 
capable of proliferation, but already express MyoD - hence they are at the myoblast stage, having 
passed beyond the unipotential threshold.  They do not begin differentiating into myocytes until proper 
growth and feeding conditions are met.  Therefore, it would be more precise to say that this thesis 
focuses on the genetic network responsible for the myoblast to myocyte transition, and then on the 
maturation of the myocyte into a myotube.  For a review of the precursor network, see Buckingham and 
Rigby 2014. 
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1.2 Primary transcriptional regulators of myogenesis 
 
Since a key feature of C2C12s is the expression of MyoD, we should begin by examining what that 
means.  The "birth" of the myogenic network can be traced back to an observation that took place over 
30 years ago - that 10T1/2 cells treated with 5-azacytidine can turn into adipocytes, myoctes or 
chondrocytes (Taylor and Jones, 1979), with myogenic conversion occurring 25 - 50% of the time.  This is 
consistent with 10T1/2s having the developmental characteristics of multipotential somitic cells.  Since 
5-azacytidine essentially releases methylation restrictions during the synthesis of the daughter genome, 
the working hypothesis first proposed by Hal Weintraub and colleagues was that there must be a single 
dominant-acting factor that can commit cells to a myogenic fate, with the downstream program 
executed upon meeting the required growth conditions.  This would account for the high rate and 
relative ease of the conversion to myoblast, and indeed led to the cloning of the MyoD cDNA by Davis et 
al. (1987).  Upon transfection under a constitutively active promoter, MyoD initiated a stable myogenic 
conversion of 10T1/2s and other fibroblast lines.  It turned out that MyoD was one of four closely 
related mammalian genes, all possessing the dominant myogenic property - together, they are 
commonly referred to as MRFs (muscle regulatory factors).  The multiple MRFs have a single ortholog in 
most invertebrate genomes, including hlh1 in C. elegans and nautilus in D. Melanogaster.  All MRFs are 
sequence-specific DNA-binding proteins of the bHLH family, and function as heterodimers with E-
proteins (also bHLH transcription factors).  The dimerization and its implications for DNA binding will be 
discussed in more detail in the next section of the introduction. 
Of the four MRFs, MyoD and Myf5 (Braun et al. 1989) are the most similar functionally and structurally.  
They are preferentially expressed in myoblasts, and a joint MyoD-/- Myf5-/- knockout results in a 
complete failure to develop skeletal muscle (Rudnicki et al. 1993), with animals dying immediately upon 
birth.  Single knockouts compensate each other and result in an apparently normal muscle phenotype 
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(Rudnicki et al. 1992; Braun et al. 1992), although the MyoD-/- genotype was subsequently associated 
with several subtler abnormalities.  Specifically, such mice were viable, but had an impaired capacity to 
regenerate skeletal muscle following injury (Megeney et al. 1996), while satellite cells carrying the 
MyoD-/- knockout form unusual aggregate structures, fail to fuse efficiently, show a severe reduction in 
differentiation efficiency, and are Mrf4 deficient (Cornelison et al. 2000).  The initial experiment 
involving a Myf5-/- knockout led to an unexpected phenotype with severe abnormalities in rib 
development, resulting in immediate postnatal lethality due to suffocation (Braun et al. 1992).  Despite 
that, the morphology of skeletal muscle in those animals remained unaffected.  After some complex 
issues involving neomorphic effects of early knockout constructs were resolved, the phenotype of   
Myf5-/- was essentially the same as that of MyoD-/-, further reinforcing the idea that MyoD and Myf5 are 
able to compensate for one another, at least insofar as the generation of viable skeletal muscle is 
concerned.  While these findings may appear surprising due to the perceived importance of MyoD to 
muscle specification and the initiation of the differentiation cascade, they are not altogether 
unexpected given the extensive sequence homology shared by the two proteins and their 
contemporaneous expression.  Because of the extensive work surrounding MyoD, and its importance to 
the system, a portion of the work presented in chapter 3 will focus on analyzing its occupancy in both 
cycling and differentiating C2C12s.  Conversely, we will not focus much attention on Myf5, primarily due 
to its much lower mRNA levels compared to MyoD (Table 3.7). 
Myogenin (Myog), identified and isolated by Wright et al. (1989), is functionally unique among MRFs 
and therefore central to this thesis.  A Myog-/- knockout leads to a severe malformation of all skeletal 
muscle, and is also lethal at birth, largely due to the absence of a functioning diaphragm and the 
resulting asphyxiation (Hasty et al. 1993).  This makes myogenin indispensable for proper myotube 
formation, and its expression pattern reflects that property.  While MyoD and Myf5 are present in 
cycling and undifferentiated myoblasts, myogenin is generally not expressed until entry into terminal 
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differentiation, at which point its drastically up-regulated in vivo and in vitro.  This puts myogenin 
downstream of MyoD and Myf5, both temporally and in the regulatory cascade - myogenin is a direct 
target of MyoD and Myf5.  What makes myogenin unique is that its the only member of the MRF family 
whose sole absence leads to a failure to form mature muscle - there appears to be no compensatory 
mechanism to account for a lack of myog.  This served as the impetus for making myogenin the primary 
focus of chapter 2. 
Finally, Mrf4 (Rhodes and Konieczny 1989), independently discovered as herculin (Miner and Wold 
1990) and Myf6 (Braun et al. 1990), was isolated and characterized based on its extensive sequence 
similarity to the other 3 members of the MRF family.  Mrf4 shares the ability to initiate fibroblast 
conversion into myocytes, and is the only one to be prominently expressed in mature muscle (both in 
mice and humans).  The other three MRFs (MyoD, Myf5, Myogenin) are generally absent in healthy 
mature muscle, although they are up-regulated during muscle repair and regeneration due to the 
activation of satellite cells.  An Mrf4 knockout results in a corresponding reduction of Myf5, and as such 
is essentially an Mrf4-/- Myf5-/- double knockout, with skeletal muscle morphology unaffected (Braun and 
Arnold 1995).  In aggregate, these data suggest that either Myf5 or MyoD must be present for skeletal 
muscle specification, while myogenin is crucial to the proper completion of the differentiation process.  
The exact function of Mrf4 is still not well understood, although it is located in very close genomic 
proximity to the Myf5 gene, which explains the initial difficulties in the generation of knockout animals. 
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1.3 MRFs and DNA binding 
 
The 4 members of the MRF family are all bHLH (basic helix-loop-helix) transcription factors (Weintraub 
et al. 1991), and bind DNA as dimers, with the helix-loop-helix motif responsible for dimerization and 
the basic domain responsible for DNA binding.  Both MyoD and myogenin heterodimerize with another 
member of the bHLH family - E47 -  in order to bind DNA (Murre et al. 1989; Chakraborty et al. 1991; 
Lassar et al. 1991), effectively making E47 a crucial 5th member of the group.  However, because the 
presence of E47 is not sufficient for myogenesis, nor is it a marker unique to skeletal muscle, it is neither 
classified nor treated as an MRF.  In fact, E47 is itself a primary regulator of B-cell differentiation (Murre 
1991; Bain et al. 1997; Lin et al.  2010), and this will be used to improve our understanding of the 
subtleties of sequence-specific targeting. 
MyoD:E47 and Myog:E47 heterodimers have for a long time been reported to bind the motif CANNTG 
(known as an e-box), but recent findings have substantially refined the definition of the recognition 
sequence for MyoD:E47 (Kophengnavong et al. 2000; Cao et al. 2010; Fong et al. 2012).  Specifically, the 
central nucleotides have a significant impact on binding affinity, with GS being most optimal, and WW 
least so.  Additionally, flanking nucleotides play an important role, with RR being the preferred prefix 
(although RY and YR are also viable, but not YY).  As such, the binding site is really better characterized 
as RRCAGSTG - part of the work presented in chapter 2 contributed significantly to this refinement.  
Even so, there are over a million RRCAGSTG motifs in the mouse genome, requiring additional 
information to identify those directly involved in muscle differentiation. 
Two additional points deserve mention.  First, E47 is a product of the E2A gene, but it is not the only 
one.  E12 - another splice isoform of E2A -  is also a bHLH protein (Murre et al. 1989a), and it is co-
expressed with E47 in both muscle and B-cells.  The transcript for E47 is more prevalent, by an  
approximately 2:1 ratio in differentiating muscle.  While E47 can homodimerize efficiently and binds 
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DNA as either an MRF:E47 heterodimer or an E47:E47 homodimer, E12 homodimers lack the ability to 
bind DNA (Shirakata and Patterson 1995).  MRFs can heterodimerize with E12, and show similar 
preferences when partnered with either E47 or E12.  Second, HEB (also known as Tcf12) is another class 
I bHLH protein expressed in skeletal muscle.  MyoD:HEB heterodimers can bind DNA (Hu et al. 1992) and 
are thought to be active in the later stages of muscle differentiation (Parker et al. 2006; Davie and 
Londhe 2011).  They appear to have the same sequence preference repertoire as their MyoD:E47 
counterparts.  
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1.4 Secondary transcriptional regulators of myogenesis 
 
Several other transcription factors have over time been strongly linked to the process of muscle 
differentiation.  Myocyte Enhancing Factor 2 (Mef2) was first postulated by Gossett et al. (1989) for its 
ability to interact with enhancers of muscle creatine kinase (ckm) and myosin light-chain 1/3 (mlc-1).  It 
was then shown that myogenin can induce Mef2 (Cserjesi and Oslon 1991) and that Mef2 in turn 
interacts with a recognition site in the myogenin promoter (Edmondson et al. 1992).  This formed the 
basis for an auto-regulation loop involving myogenin and Mef2, and coupled with the ability of Mef2 to 
activate highly muscle specific genes led to the conclusion that it must be crucial to myogenesis.  While 
technically correct, the initial results were an oversimplification due to being based upon the detection 
of a specific protein-DNA complex.  We now know that Mef2 is a MADS-homeobox transcription factor, 
and that in mouse it is not a single gene, but instead a family of four similar yet distinct genes 
designated a through d (Martin et al. 1993).  The four Mef2 genes are highly homologous in the 56 
amino-acid MADS domain responsible for DNA binding and dimerization, although they are divergent at 
their carboxyl termini (Edmondson et al. 1994).  They bind DNA in the form of dimers, and with their 
relative levels changing over the course of differentiation, so changes the exact nature and 
concentration of the available species.  For instance, Mef2a:Mef2a and Mef2a:Mef2d are both able to 
recognize the cannonical binding site CAT(W)4TAG (Nurrish and Treisman 1995) but show up as distinct 
bands on a mobility shift assay and are likely present in different amounts in myoblasts versus myocytes 
(thesis results, chapter 4).  They can also be recruited to DNA through protein-protein interactions, 
because myogenin:E12 heterodimers and Mef2c were jointly co-precipitated as a protein-DNA complex 
in the presence of an e-box motif but not the CAT(W)4TAG site (Molkentin et al. 1995).  Knockout mice 
that are Mef2a-/- were born alive, but most died within 10 days from cardiac failure likely caused by 
severe ventricular chamber dilation (Naya et al. 2002).  Some Mef2a-/- mice survived to adulthood, and 
showed a deficiency in cardiac mitochondria, but without obvious structural defects of the heart.  
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Neither population exhibited any apparent skeletal muscle abnormalities.  While this knockout result 
strongly implies that Mef2a is important to the proper function and development of myocardial muscle, 
its implications with regard to skeletal muscle differentiation are less clear.  In addition to being active in 
cardiac muscle (Edmondson et al. 1994), members of the Mef2 family also function in neurons (Lin et al. 
1996), and remain a studied regulator of myogenesis (Snyder et al.  2013; Liu et al.  2014) due to their 
known ability to regulate the expression of several muscle-specific genes.  Chapter 3 will test some of 
the expectations about the genomics of Mef2 in differentiating C2C12s and examine its occupancy. 
RP58 (also known as ZFP238 and ZNF238) is a POZ zinc-finger repressor first identified by Aoki et al. 
(1998), and shown to bind the CAGATGT motif.  It was also reported that DNA methyltransferase 
Dnmt3a functions as a co-repressor with RP58 in a manner that does not require its methyltransferase 
activity (Fuks et al. 2001).  The e-box-containing recognition sequence is very similar to the RRCAGMTG 
site proposed for NeuroD2 (Fong et al. 2012), and not surprisingly RP58 was initially detected in 
developing neurons and linked to the regulation of neurogenesis (Ohtaka-Maruyama et al. 2007; Okado 
et al. 2009).  However, RP58 is also expressed, albeit to a lesser degree, in skeletal muscle, and its mRNA 
levels increase substantially upon entry into terminal differentiation (Chapter 3, Table 3.7).  
Furthermore, RP58 has flexibility in its binding site, and can bind CAGCTGT motifs, which often overlap 
recognition sequences for myogenin (I observed this behavior in 2008 while working on regulation of 
human GPR41, albeit without linking it to myogenesis at the time).  In 2009 Yokoyama et al. 
demonstrated that levels of Id2 and Id3 (both historically important repressors of MyoD that will be 
discussed shortly) increase when RP58 is knocked down.  Simultaneously, an RP58 knockout study 
(Okado et al. 2009) revealed that RP58-/- mice exhibit defects in muscle development, with a significant 
reduction in the number of myofibers found in the hind-limb and a severe impairment of diaphragm 
development, resulting in immediate postnatal lethality.  This work was followed up establishing that 
RP58 can interact directly with sequences in promoters of Id1-4, and that its absence leads to increased 
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expression of reporter constructs (Hirai et al. 2012).  While the latter was done in astrocytes, it stands to 
reason that the same mechanism is applicable in skeletal muscle.  The implications of RP58 binding 
CAGCTGT, which often overlaps MRF:E targets (RRCAGSTG), and suggests a fluid, competitive regulatory 
apparatus, will be discussed in Chapter 4. 
It would be remiss not to acknowledge the Id family of repressors, despite the fact that they are not 
transcription factors, and therefore fall outside the scope of this investigation.  Inhibitor of 
differentiation (Id) was first isolated by Benezra et al. (1990) during a search for proteins with homology 
to the HLH domain of MyoD and c-myc (another member of the bHLH family, most famous for its role as 
an oncogene).  While Id does have an HLH domain, which allows it to heterodimerize with members of 
the bHLH family, it lacks the basic domain, in turn making the resulting heterodimers unable to bind 
DNA.  Id was shown to heterodimerize with E47, E12, and MyoD (Benezra et al. 1990), which drastically 
reduced the ability of those proteins to interact with known targets, such as the ckm enhancer.  The 
"titrating" nature of Id repression was confirmed through the use of tethered dimers, where MyoD and 
E47 monomers were joined by a short peptide bridge, virtually ensuring complete dimerization.  The 
resulting MyoD~E47 species was able to efficiently bind target sequences in vitro despite a high 
concentration of Id, and served as a potent initiator of myogenesis in 10T1/2 and NIH3T3 cells - neither 
line is inherently myogenic (Neuhold and Wold 1993).  In mammals, the Id family consists of four 
homologous members, Id1-4, the first three of which are heavily expressed in myoblasts along with 
MyoD and Myf5.  All three are also significantly downregulated (over 90% reduction in transcript 
abundance - thesis data) upon cell cycle exit and entry into terminal differentiation.  The Id genes 
competitively mitigate the effects of various tissue-specific bHLH transcription factors in a variety of 
setting, including hematopoietic (Deed et al. 1998), neuronal (Cai et al. 2000), muscle (Benezra et al. 
1990) and adipose (Moldes et al. 1999).  While undoubtedly important to curating the function of bHLH 
TFs, the exact physiological role of Ids in myogenesis remains unclear.  In the C2C12 system, the 
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myoblast stage shows high levels of transcripts for MyoD, Id1 and Id3; with lower levels for Myf5, Id2, 
Tcfe2a (E12/E47) and HEB (RNASeq data).  The initial Benezra et al. (1990) result was extended by 
Langlands et al. (1997) to show that Id1-3 have a high dimerization affinity for all class I bHLH proteins 
present in differentiating muscle (E12/E47, HEB, and also E2-2), although their dimerization affinities for 
members of the MRF family vary by species of Id and MRF.  Since MyoD requires either HEB or E47 to 
bind DNA, their availability appears to be the limiting factor for the formation of the MyoD:E complex.  
Furthermore, despite high levels of Ids, MyoD is clearly able to perform its role as a positive regulator of 
transcription, and drive the transition to the myocyte stage (where, as noted above, transcript levels for 
Id1-3 fall dramatically).  Given this, one reasonable interpretation is that the primary role of Ids is to shift 
the equilibrium away from the formation of E47:E47 homodimers, which are "inappropriate" for 
myogenic differentiation, with perhaps a secondary role of titrating the concentration of active MyoD.  
The latter would then help account for the temporal patterns inherent in the network. 
ZEB (zinc finger e-box binding protein) is a repressor that, based on its name alone, one might expect to 
play a role in the regulation of myogenesis.  Much like RP58, it was first described in a non-myogenic 
context - while studying the immunoglobulin heavy-chain (IgH) enhancer, Genetta et al. (1994) cloned 
and characterized a zinc-finger protein (ZEB) that was able to bind the e-box sequence CAGGTG (an 
important element of said enhancer).  They then demonstrated that ZEB and E:E homodimers bind that 
e-box in vitro in a competitive, concentration dependent manner by abolishing the E:E~CAGGTG 
complex in the presence of a large molar excess of ZEB, and vice versa.  It was then pointed out that ZEB 
is a mammalian homolog of the Drosophila gene Zfh1, which is expressed in muscle precursors and is 
crucial to the proper development of muscle (Postigo and Dean 1997).  The same study indicated that 
although ZEB is able to act as a transcriptional repressor, the repression is lost upon expression of 
MyoD, without decrease in the level of ZEB (in fact, the abundance of ZEB1 transcript increases 
significantly after cell cycle exit, in a manner similar to that of RP58).  More recent efforts in identifying 
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the role of ZEB in myogenesis involved a targeted knockdown of ZEB1 in differentiating C2C12s (Siles et 
al. 2013), leading to an earlier than expected expression of molecular markers associated with 
myogenesis and accelerated myotube formation.  By examining the occupancy of CAGGTG elements in 
the promoters of troponin and MyH4, the authors also concluded that ZEB is present in myoblasts but 
not myocytes, with the opposite true of MyoD occupancy.  These data formed the impetus for 
considering the importance of ZEB in myogenesis vs. B-cell differentiation (discussed in chapter 4), 
providing further evidence for a fluid attenuation model of transcriptional regulation.  The physiological 
function of ZEB in myogenesis appears to be more about imposing temporal control on MRF-based 
activation of transcription rather than about direct repression of MRF targets, although instances of the 
latter cannot be entirely ruled out. 
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1.5 Aims of the thesis 
 
At the time I began this work, myogenin was a relatively less-studied transcription factor, with the 
majority of attention in the field focused on understanding the targets and kinetics of MyoD.  High-
throughput sequencing was just becoming widely available, and the immediate first step was to utilize it 
in combination with chromatin immunoprecipitation to assess the binding properties of myogenin in 
vivo.  The genome-wide map of myogenin occupancy served as the launching pad for the investigation 
of myogenesis, and is discusses at length in chapter 2.  Some of the issues addressed are the number of 
occupied sites, their distribution relative to annotated TSSes and gene models, motif content, and 
association with expression patterns of nearby genes.   
Since myogenin does not operate in a vacuum, a logical next step was to consider occupancy for other 
transcription factors that are either directly involved in myogenesis, or are active in C2C12s.  Among 
them are MyoD, Mef2, E47, Fosl1 (one of the components of the AP-1 complex), CTCF, Klf4, and others.  
Using data either generated in our laboratory or published in the literature, I conducted a comparative 
analysis of occupancy profiles, their changes during state transition (myoblast to myocyte), and the 
underlying motif content.  These results are presented in chapter 3.   
Finally, because E47 is an important regulator of B-cell differentiation, and at the same time a partner 
crucial to the ability of MRFs to bind DNA and perform their roles, E47 occupancy in B-cells was 
compared with MRF occupancy in muscle cells.  Using underlying sequence biases, a model was 
formulated to partially account for the enforcement of context specificity, despite the use of TFs that 
recognize virtually identical binding sites.  These findings are presented in chapter 4, with the overall 
goal of better understanding transcription factor targeting.  Chapter 4 also presents a synthesized view 
of how different transcription factors interact in a physiological setting, with emphasis on dynamic, 
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competitive interactions, where affinity (and therefore activity) is influenced by both the subtleties of 
DNA sequence, as well as the availability of active species able to recognize it.   
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Chapter 2:  Genome-wide analysis of myogenin occupancy in differentiating 
skeletal myocytes. 
 
2.1 Introduction:  genome-wide occupancy mapping for a better tomorrow 
 
At the inception of this project, relatively little was known about the number and nature of direct 
myogenin targets, although an attempt to broadly map them using ChIP-chip (Blais et al. 2005) yielded a 
list of 198 genes thought to be directly regulated by either MyoD, myogenin or Mef2.  Work was also 
done studying DNA binding affinities, although focusing on that of MyoD, and the recognition site 
narrowed from the total e-box motif CANNTG to the "myogenic" e-box CAGSTG (CAGCTG and CAGGTG) 
(Blackwell and Weintraub 1990; Huang et al. 1996; Kophengnavong et al. 2000).  While CAGCTG can be 
recognized and bound by multiple bHLH proteins with varying lineage specificities (more on that in 
Chapter 4), for the purposes of defining sites favorable to MRF occupancy CAGSTG was indeed a correct 
and useful refinement.  This reduced the total pool of potential occupancy sites in the mouse genome 
from 14.2 million down to 2.7 million, but the remaining number of targets was intractably large for 
individual investigation.  Fortunately, a technique for mapping whole-genome transcription factor 
occupancy by coupling chromatin immunoprecipitation and high-throughput sequencing (ChIPSeq) had 
just been developed by a collaboration that involved a colleague (Mortazavi et al. 2007).  A high quality 
genome-wide occupancy map would answer the question of which CAGSTG e-boxes are occupied almost 
at a glance, as well as aid in a more thorough identification of target genes. 
Beyond the search for target genes and assessing the number of occupied sites, several other questions 
could be addressed by a myogenin occupancy determination.  Sequence content analysis of occupied 
regions can be used to refine, or verify, the primary motif, and to help in the search for likely 
collaborating transcription factors.  Conservation at and around occupied sites can be compared to 
conservation at large.  Occupied sites can also be classified based on their association with genes 
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belonging to a particular expression category, with the goal of identifying common properties within a 
class and distinguishing properties between classes.  For example, every gene that had been studied as a 
direct target of myogenin was one highly specific to muscle, and whose expression increased 
dramatically in differentiating myocytes - would that pattern persist in the global map, or would there 
be a substantial number of associations with genes following different expression trajectories?   
To answer these and other questions, and to gain a better understanding of myogenin's role in skeletal 
muscle differentiation, a genome-wide occupancy map was determined using cultured C2C12 cells, 
harvested 60 hours after withdrawal of serum, which triggers terminal differentiation.  
Immunoprecipitation was performed using a monoclonal antibody against myogenin (F5D) (Wright et al. 
1996) and following the protocol from Mortazavi et al. (2007).  Sequenced fragments (Illumina) were 
mapped to the mm9 mouse genome assembly using Eland and consolidated into regions of predicted 
occupancy using ERANGE (Mortazavi et al. 2007).  Two stringency thresholds were used to survey the 
data, producing 14786 and 27765 candidate regions for, respectively, the high confidence (HC) and 
medium confidence (MC) settings (see Methods).  For simplicity, the bulk of the discussion will focus on 
the HC set of regions, although comparable results from the MC set will be mentioned when necessary.  
Typical ChIPSeq region length was between 400 and 600 nucleotides, reaching four kilobases at the 
upper extreme (Table 2.1).  Inspection of the small fraction of very long regions (> 800 nt) found that 
they have multiple motif instances.  The resulting overlap of sequence reads in such regions was 
interpreted by the peak calling algorithm as a single, continuous region. 
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2.2 Associating myogenin occupancy with gene expression during differentiation 
 
Regions occupied by myogenin were associated with genes by proximity to the nearest transcription 
start site (TSS), regardless of directionality (see Methods).  In the absence of a direct measure of physical 
connectivity, such as ChIP-PET (which has only recently become possible) proximity on the chromosome 
was an unbiased and rational way for associating occupancy events with their candidate target gene.  
The distribution of distances between region peak and nearest TSS generally followed an inverse log 
distribution (Figure 2.2), with 14% of sites (2034) located within ± 1000 bp of an annotated TSS.  Of 
these, three quarters (1597, 10.8%) were actually within ± 500 bp.  Of the 31680 RefSeq gene models 
used in measuring gene expression, approximately 23% (7240) had at least one associated myogenin 
region.  To better understand the type of genes likely to have a proximal myogenin site, the entire set 
was classified into groups based on differential RNASeq levels at 4 time points - undifferentiated 
(cycling), differentiating (60 hours), differentiating (5 days) and differentiating (7 days).  Genes that were 
significantly (5x) up-regulated during myogenesis were classified as "myocyte" genes, while those 
significantly down-regulated (5x) were classified into the "myoblast" category.  Genes showing a stable 
level of expression (no more than 2x variation either up or down) were called "flat", and genes showing 
no expression beyond the margin of error at any of the 4 time points were classified as "unexpressed".  
This method of classification resulted in a substantial number of genes that didn't fit into either of the 
four categories, and collectively they comprise a 5th group - "undetermined" (sometimes referred to as 
"wobbly").   
While 68% of myocyte-specific genes had an associated myogenin region - by far the highest fraction out 
of the five categories, they account for only 5% of the total number of associated genes (Figure 2.3b, 
2.3c).  Perhaps surprisingly, at least at the time this was first observed, 57% of genes with an associated 
myogenin occupancy event fell into either "flat" or "undetermined" categories, showing a large amount 
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of promiscuity with regard to target gene behavior (Figure 2.3b).  Similarly, of the 14786 myogenin 
regions, only 6.7% were associated with muscle-up genes, while 69% were associated with either flat or 
wobbly genes (Figure 2.3d).  All associations by expression group were statistically different from each 
other (p < 0.0002), with order of likelihood of having a myogenin region following the coverage table in 
figure 2.3C (muscle up > flat > muscle down > undetermined > unexpressed).  Muscle up genes were 
also likely to have a higher number of myogenin regions associated with them than members of the 
other expression groups (Figure 2.4).  Absolute transcript abundance of the gene did not have a 
significant impact on the average number of occupancy events per gene - only heavy up-regulation (five-
fold or more) mattered.   
While these findings support the importance of myogenin to the regulation of muscle-specific genes,  
the majority of observed myogenin occupancy events (93%) did not associate with genes belonging to 
the muscle up category (Figure 2.3d).  We now know that this is consistent with the behavior of other 
transcription factors from the bHLH family, including MyoD, NeuroD2, Tal1, and E47 (Cao et al. 2010; 
Fong et al. 2012; Kassouf et al. 2010; Lin et al. 2010); and suggests that myogenin fulfills a significant 
"housekeeping" role in addition to acting as a master regulator of myogenesis.  In fact, the most 
statistically significant difference observed in this analysis was also perhaps the most stunningly obvious 
one - genes that have a myogenin association are more likely to be expressed than those that do not.  
One way to think about this is that as long as a region of chromatin is accessible and has a binding site 
not being actively blocked by a competitor, myogenin will occupy it some fraction of the time. 
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2.3 Sequence content of myogenin-occupied regions. 
 
2.3.1  Refining myogenin primary motif based on the in vivio occupancy repertoire 
 
Many introduction sections of papers published on the subject of myogenesis to this day cite the generic 
CANNTG e-box motif as the recognition site for MRFs specifically and for bHLH transcription factors in 
general.  This is perhaps true if literally taken as the sum of all binding preferences of all members of the 
bHLH family, as diverse as they are:  MyoD, myogenin, NeuroD, Tal-1, c/l-myc, Twist (Ozdemir et al. 
2011) to name a few of the more 600 surveyed in a recent phylogenetic study (Stevens et al. 2008; 
Skinner et al. 2010).  However, it is clearly a misrepresentation of the binding preferences of the MRFs 
themselves.  For that matter, when they are considered individually, its not representative of any of the 
other transcription factors named above.  Different bHLH proteins have different preferences for the 
two central nucleotides, and often exhibit biases for flanking base pairs as well.  Understanding this 
specificity is crucial to understanding the regulatory networks governed by these transcription factors, 
and the possible interactions they may have with one another.  
At the time this measurement was done, most evidence pointed to CAGSTG as the likely target site for 
MyoD:E (as discussed in section 2.1), and functional studies of elements regulated by myogenin 
suggested the same would be true of Myog:E (Brennan and Olson 1990; Prody and Merlie 1992; Catala 
et al. 1995).  A genome-wide occupancy map was the perfect opportunity to assess the accuracy of this 
prediction, so both matrix mapping and de-novo motif discovery were used to analyze myogenin-
occupied regions.  To make the data more uniform and easier to interpret and process, regions were 
restricted to ± 250 bp from the computational peak.  This was done in part to remain consistent with the 
average region length, and in part to allow detection of potential co-factor binding sites that might be 
located 100 - 200 bp away from the primary myogenin target.  It was additionally informed by an 
analysis of conservation done by a colleague in the lab, which found that preferential conservation 
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around these ChIPSeq peaks covered ~ 400 bp (Pepke, unpublished).   Using longer regions was not 
desirable because doing so would dilute enrichment of sites and place more computational strain on de 
novo motif finders. 
The hexamer CAGSTG is indeed present in a vast majority of myogenin regions (87.0% HC, 80.6% MC) 
(Table 2.5), and its frequency is significantly (p < 0.01) enriched over genomic background (Figure 2.6a).  
It was also derived de novo by MEME from virtually any subset of myogenin occupancy data consisting 
of at least 100 HC regions, including the set of 100 weakest regions ranked by the strength of ChIPSeq 
signal they presented.  One noteworthy observation from the de novo searches is that the matrices 
reported by meme consistently included the octamer RRCAGSTG, which served as the impetus for 
measurements that I will discuss below.  Both components of the CAGSTG motif (CAGCTG and CAGGTG) 
were centrally concentrated in myogenin regions (Figure 2.6c), with density dropping sharply when 
looking more than 100 nucleotides away from the computationally defined peak.  A majority of 
myogenin HC regions (8237, 55.7%) contained more than 1 CAGSTG, which can be interpreted 
biologically as support for the notion of collaborative binding (Weintraub et al. 1990; Neuhold and Wold 
1993), and technically as an indication that regions with multiple CAGSTG motifs are more likely to 
produce a strong ChIPSeq signal.  The latter will be discussed in section 2.4.  The number of CAGSTG 
motifs present in the region did not correlate with the expression profile or mRNA levels of the 
associated gene. 
The hexamer motif was then expanded to include the RR prefix suggested by meme searches and hinted 
at by Blackwell and Weintraub (1990).  The same bias was independently reported for MyoD by Fong et 
al. (2012) and can be observed in the myogenin occupancy data from Mousavi et al. (2013), although the 
latter did not report on the sequence content of their occupancy determination.  The RRCAGSTG 
octamer covered 76% of myogenin regions (compared to 87% for the hexamer), with strongest 
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enrichment within a 100 nucleotide radius around the computational peak (Figure 6c).  It turned out 
that 75% of all CAGSTG e-boxes contained in the myogenin ChIPSeq regions were of the RRCAGSTG form 
- a startling enrichment (p < 0.0001) compared to the genome at large (27%).  Genome-wide RRCAGGTG 
and RRCAGCTG occur at a similar frequency - 495K vs. 560K occurrences per genome, respectively, but 
the GC version dominates in myogenin regions, by a ratio of 2.7:1, which is a highly significant bias (p < 
0.0001).  Why would GC be concentrated nearly threefold with respect to GG?  This will be examined in 
more detail in chapter 4, but its interesting to note that many of the early myogenin targets described 
functionally by enhancer mutagenesis were of the GG variety, so this observation was not expected.  
These data reinforced the idea of an octameric binding site, rather than the classically thought of 
hexamer.  There was no correlation between the central nucleotides of the e-box (GC vs. GG) or its 
prefix (RR vs. non-RR) and the expression pattern of the associated gene.  There does appear to be a 
stronger pressure on CAGGTG e-boxes to have the RR prefix than on their more numerous CAGCTG 
counterparts, and a potential reason for why that is will also be proposed in chapter 4. 
2.3.2  Candidate motifs for collaborating and modulating functions 
 
Based on detailed studies of canonical muscle differentiation enhancers, MRFs often act in conjunction 
with other transcription factors in CRMs (cis-regulatory modules) to exert the regulatory effect.  
Partnership with Mef2 at the ckm promoter has already been discussed in the introduction.  It was also 
shown that MyoD and Sp1 jointly act to induce the cardiac alpha-actin promoter in skeletal muscle 
(Biesiada et al. 1999), and MyoD has been reported to collaborate with Pbx/Meis (Maves et al. 2007) to 
regulate myogenin.  A variety of CRMs with differing additional factor sites are likely to exist.  On the 
simple end of the spectrum, modules might consist of two or three sites for different TFs (all of which 
are expressed in a given lineage) in close proximity to one another, where joint occupancy is needed for 
activation of the target gene.  On the other extreme, complex modules containing permissive sequences 
26 
 
recognized by a wider variety of transcription factors present in different developmental lineages or cell 
types, where subtleties in affinity coupled with additional tissue-specific elements ultimately modulate 
transcriptional output differently across a number of cell types.  A genome-wide occupancy map 
provides an excellent avenue to search for such regulatory elements and for evidence of transcription 
factor collaboration via joint presence of recognition sites. 
In addition to de novo searches using MEME, an extensive motif mapping effort was undertaken.  It 
included a variety of e-box sequences, recognition sites for transcription factors previously reported to 
collaborate with MRFs, and a number of motifs taken from JASPAR (only motifs with reasonably high 
information content were taken).  While a filter could have been applied to only search for binding sites 
of TFs actually expressed in cycling or differentiating C2C12s, such a winnowing could have predisposed 
the analysis towards missing "negative interactions" - motifs depleted in myogenin-occupied regions 
due to functional pressure for keeping certain networks separate.  In addition to the octamer 
RRCAGSTG, MEME was able to derive versions of the AP-1 and Runx motifs from several subsets of 
myogenin regions - these matrices were added to the mapping database.  Motif maps were then used to 
determine relative frequencies with which various sites were encountered (see Methods).  There was an 
over-representation (p < 0.01) of binding sites for AP-1, Meis, Runx, Sp-1, c-Myc, Usf1, CTCF, and Klf4 
(Figure 2.6a).  The first three were reported to be associated with MyoD occupancy in myotubes, and we 
know that 82.3% of myogenin-occupied regions in myotubes are also occupied by MyoD (Cao et al. 
2010, Chapter 3).  Contrary to current expectation, there was a significant depletion (p < 0.01) of the 
Mef2 half-site AAATAG said by Cao et al. (2010) to be co-enriched with MyoD.  A behavior more in line 
with previously known biology, where myogenin and Mef2 collaborate positively at a few well studied 
myocyte enhancers, was observed when using the canonical Mef2 site (CTAWWWWTAG).  The latter 
occurs at background frequency in the myogenin ChIPSeq dataset as a whole, but I found it to be 
enriched in the subset of regions associated with muscle-up-regulated genes (Figure 2.6a).  Despite this 
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confirmation of enrichment for myocyte-up-regulated genes, the total number of Mef2 sites falling 
within myogenin regions is relatively small - 229 total sites, 29 of them in regions associated with 
muscle-up genes, especially in light of its commonly accepted role as a crucial regulator of myogenesis.  
The observation of infrequent Mef2 sites agrees with the results of a Mef2 ChIPSeq determination on 
myocytes in the same stage of differentiation (Fisher-Aylor unpublished; Chapter 3).  One explanation 
for this is that cases like the ckm enhancer, where Mef2 and MyoD/Myog have binding sites in relatively 
close proximity to one another, and have been proven by mutagenesis to be necessary for full 
enhancing activity of the corresponding CRM, are the exception rather than the rule.  It is also possible 
that Mef2 operates at other sites without its primary recognition motif, relying instead on protein-
protein interactions with MyoD or myogenin.  This question will be addressed further in Chapter 3, 
where results of a Mef2a ChIPSeq and their correlation with the myogenin data will be analyzed. 
Three promoter-associated motifs stood out in the analysis, but for different reasons.  There was a very 
strong depletion (p < 0.01) of TATA-like motifs in all myogenin-occupied regions, most especially those 
that are promoter proximal.  The TATA motif was also depleted in the dataset as a whole, being true for 
all stratifications by distance from the nearest TSS.  The depletion of TATA motifs in regions far from any 
known TSS is, unlike promoters, consistent with its known function.  Conversely, CGCGCG, a reported 
target for the for the Cfp1 subunit of the Set1 H3K4 methyltransferase complex (Clouaire et al. 2012), 
and the Sp1 motif CCGCCC, both promoter-associated (Figure 2.9a), were significantly (p < 0.01) 
enriched.  The enrichment was very prominent in myogenin regions centered within 2500 bp from the 
nearest TSS, but persisted in other groups and in the dataset as a whole (Figure 2.6b).  Because the G/C 
content of myogenin regions was not significantly different from the genome at large these differences 
likely suggest function.  The Sp1 result is consistent with previous work, and points to a number of 
promoters where MRFs and Sp1 joint occupancy leads to transcriptional activation.  Taken together, 
TATA-box and CGCGCG data suggest that the myogenic network may rely less on TATA-linked promoters 
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and more on those controlled by initiator regions where CGCGCG tends to be abundant.  Alternatively, 
the presence of CGCGCG could be indicative of DNA methylation/demethylation playing an active role in 
controlling the activity of that subset of promoters, at least in the C2C12 cell line - a question that could 
benefit from further investigation focused on DNA methylation patterns in this system. 
2.3.3  Repressor motifs in myogenin regions 
 
Myogenin-occupied regions contain a higher than expected number of recognition sites for the 
repressive regulator Klf4, which is thought to play a role in regulating the cell cycle and can function as 
either an oncogene or a tumor suppressor in a context-dependent manner (Rowland and Peeper 2006).   
It is also implicated in triggering membrane fusion as multinucleated myotubes form (Sunadome et al. 
2011).  The G-rich Klf4 site is most heavily present in promoter-proximal myogenin regions (Figure 2.6b), 
but is enriched throughout the entire dataset.  Its frequency is not influenced by the expression 
behavior of the associated gene (Figure 6a), and its central tendency is much lower than that of other 
secondary motifs.  An alternative explanation is that  Klf4 sites are preferentially promoter-proximal, 
leading to a higher rate of coincidental overlap (Figures 2.9a and b). 
The consensus binding site for bHLHb2/Dec1 - an orange-class transcriptional repressor (Sun et al. 2007) 
up-regulated during myogenesis - is globally enriched in myogenin regions.  Further analysis shows 
myogenin regions associated with muscle up genes do not have an enrichment for this repressor site, 
while regions associated with all other gene categories do (Figure 2.6a).  It is important to note that this 
version of the Dec1 motif, as well as the Usf1 site, contain the myc-class e-box CACGTG, suggesting a 
need for a finer parsing of binding preferences of these transcription factors.  Unfortunately, multiple 
attempts to generate a Dec1 occupancy map in C2C12s via ChIPSeq failed consistently, and as a result a 
direct derivation of the consensus site via sequence analysis has not been done. 
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CTCF is an 11-Zinc finger transcription factor that is highly conserved in most vertebrates (Filippova et al. 
1996), and has been associated with transcriptional repression (Baniahmad et al. 1990), activation 
(Klenova et al. 1993) and most prominently insulation (Bell et al. 1999).  It was first described as a 
regulator of c-myc in gallus gallus (Lobanenkov et al. 1990), but has since been ascribed a variety of 
functions having to do with chromatin structure and remodeling - such as facilitation of chromatin 
looping (Splinter et al. 2006).  It is also theorized that CTCF uses different combinations of zinc fingers in 
different situations (Filippova et al. 1996), which makes defining a fully informative ubiquitous 
recognition motif more challenging.  A version of the CTCF site derived from its occupancy map in 
differentiating myocytes (Mikkelsen unpublished) was over-represented in myogenin-occupied regions, 
with heaviest enrichment in promoter-proximal regions - this is consistent with the overall enrichment 
for CTCF sites observed in TSS-proximal regions (± 250 bp from TSS) (Figure 2.9b).   However, the CTCF 
motifs encountered in myogenin-occupied regions had a central positional tendency that is unlikely to 
arise purely from accidental overlap.  There was a slight bias towards regions associated with genes 
down-regulated during myogenesis, although that tendency was not as pronounced as the one dictated 
by distance to the nearest TSS.   
2.3.4  Non-CAGSTG e-box motifs in myogenin regions 
 
To further address the question of how CANNTG motifs correlate with myogenin occupancy, all possible 
e-box sequences (accounting for the reverse complement) were mapped and their densities calculated.  
There was a heavy depletion of the CAWWTG class e-boxes associated with Twist (Kophengnavong et al. 
2000).  The depletion was more prominent in promoter-proximal myogenin regions, but turned out to 
be a feature of the aggregate sample as well (Figure 2.6d).  Two explanations arise for this observation.  
First, there is evidence of functional impetus for keeping the two networks separate, as expression of 
Twist and Myf5 are mutually exclusive (Hebrok et al. 1994), resulting in a depletion of Twist-like sites in 
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areas of genome active during myogenesis.  Recent findings in drosophila (Ozdemir et al. 2011) suggest 
Twist frequently uses the CACATG e-box motif, and that CATATG sites may require additional inputs to 
be properly activated by Twist, if these biases extend to mammals.  This deserves further investigation, 
as it could be evidence of fine-tuned Twist targeting, or it could be evidence of difference between 
drosophila Twist and mouse Twist.  The CACATG motif is also slightly but significantly (p < 0.01) depleted 
in myogenin-occupied regions.  Second, there is a general depletion for these motifs in close proximity 
to annotated TSSes (Figures 2.9a and 2.b), likely to limit the occurrence of spurious translation start sites 
(ATG).  When taken together, these two phenomena help account for both the general lack of CAWWTG 
in myogenin-occupied regions, and for the even heavier depletion observed specifically in the TSS-
proximal subset.  There was also a twofold enrichment (p < 0.01) for CACGTG myc-class e-boxes.  
Otherwise, there was a lack of appreciable enrichment or depletion for any e-box that didn't belong to 
the SS or the WW classes (Figure 2.6d).  While all density differences discussed were above the 
threshold for statistical significance (p < 0.01), the absolute rate of incidence for non-SS, non-WW e-
boxes was always in the range of 0.9 - 1.2x whole genome rate, even for the CACATG Twist site, which 
correlates with results obtained from analyzing randomly selected regions.  Beyond biological 
implications of enrichment and depletion above, these data should definitively put to rest the notion of 
CANNTG being the reference binding site for myogenin or MRFs as a group. 
2.3.5 Conservation of RRCAGSTG motifs in myogenin regions 
 
Conservation has been a traditional, if not always reliable, measure of functional importance of a given 
DNA element.  High conservation across multiple species, and especially across phyla, often highlights 
sequence areas that are either involved in multiple pathways or are essential to the survival of the 
organism, and as a result are under selective pressure against change.  While a conserved element is 
likely to have some functional importance, the reverse is not necessarily true.  Non-conserved elements 
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can also be functional if they arose recently or belong to a system that is in some way unique to the 
organism being investigated.  Finally, the definition of the word "functional" can itself be debated, so 
perhaps a better way to phrase this is to say that conserved elements have a higher probability of being 
"necessary" - their destruction or significant alteration is more likely to have deleterious consequences.  
That having been said, conservation of sites occupied by myogenin was natural to consider.  Of the 
slightly over 1 million RRCAGSTG motifs present in the mouse genome, only ~23,500 are occupied by 
myogenin.  Are those 23,500 motifs more likely to be conserved than the other ~1,000,000?  And if so, 
what fraction are conserved?  Will conservation serve as a good predictor of occupancy?  Note that 
these motif totals are somewhat different from those used for enrichment calculations, where simple 
repeats were filtered out prior to computing density.  A repeat could be conserved, hence the entire 
motif population was used for this analysis. 
The results matched expectation - RRCAGSTG motifs in regions occupied by myogenin are more likely to 
be conserved than those in the genome at large.  The exact fraction varies depending on the stringency 
of conservation required and the set of phastCons scores used, so after extensive testing the placental 
mammals set of phastCons scores was used with 0.7 entropic conservation threshold (see Methods).  
Under those parameters, 11.7% of all RRCAGSTG motifs are conserved in the whole genome, whereas 
26.6% of RRCAGSTG motifs are conserved in regions of myogenin occupancy.  This represents a 
significant (p < 0.0001) increase in the frequency with which conserved motifs are encountered, 
although it is interesting that it does not account for the majority of observed occupancy.  If only 
conserved motifs are considered, 5.1% of available RRCAGSTG sequences are occupied by myogenin in 
differentiating myocytes (versus 2.2% if conservation is not factored in).  While not a good predictor of 
occupancy, conservation can be useful for selecting candidate regions to undergo functional testing. 
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2.4 Correlation between signal intensity and  motif content 
 
Another question pertinent to the evaluation of the myogenin occupancy data was about the meaning 
of observed signal strength - a normalized measure of the total number of sequenced reads mapping 
within the genomic boundaries of the identified region.  Does signal intensity correlate in any 
meaningful way with motif content or, perhaps more interestingly, with the behavior of the associated 
gene?  It quickly became clear that there is some positive correlation between the observed number of 
reads and the number of RRCAGSTG motifs present in the region (Figure 2.7a).  For comparison, the 
same analysis was performed using the AP-1 recognition motif CTAGTCA, and showed no correlation 
between the number of AP-1 motifs and signal intensity (Figure 2.7b).  While longer regions are more 
likely to contain more copies of the RRCAGSTG octamer, the correlation remains true even when regions 
are normalized for length. 
The relationship between signal intensity and associated gene expression is weak, if present at all.  
Several analyses designed to detect a positive quantitative relationship, differing in input and method, 
all showed remarkably little effect.  A representative example is shown in Figure 2.8, which takes each 
region-gene association and compares ChIPSeq signal intensity and transcript levels at 60 hr after 
withdrawal of serum.  The red category represents only the top 10% strongest myogenin regions (by 
ChIPSeq signal intensity), while the blue category represents all HC regions.  There is no significant 
correlation in either case:  R = 0.01 for the strongest 10%, R = 0.05 for all regions combined.  The same 
conclusion holds true if myogenin ChIPSeq signal strengths from all sites associated with a gene are 
summed together first.  Similarly, there is no correlation between ChIPSeq signal strength and the 
category of the gene expression profile, using the expression categorization method described in section 
2.2.  In fact, the most statistically significant correlation (by a χ2 test, p < 0.0001) is the same one 
discussed in section 2.2 - genes with an associated myogenin region are more likely to be expressed than 
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those without one.  This conclusion, while in many ways obvious, raises a "chicken or egg" question - 
does myogenin occupancy lead to the expression of neighboring genes, or are the genes being 
expressed by definition in areas of open chromatin, which allows myogenin occupancy, but without 
noticeable effect on the levels of transcription.  The answer, undoubtedly, is a combination of the two 
(we know myogenin is crucial to the expression of many genes, both in vivo and in vitro), but the relative 
contribution of each phenomenon remains unknown.  Functional assays can shed light on the likelihood 
of a given element's ability to influence transcriptional output, though even that is not necessarily a full  
reflection of its physiological function when it has one (or more). 
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Figures and Tables (chapter 2) 
 
 
 
Myogenin HC Myogenin MC 
Number of regions 14,798 27,793 
Nucleotide coverage 7,923,964 9,742,958 
Read % in regions 22.37% 25.98% 
Average region length 534 351 
Median region length 481 311 
Length standard deviation 279 151 
Minimum length 70 52 
Maximum length 3,793 2,071 
 
Table 2.1.  Primary characteristics of the myogenin occupancy measurement and comparison between 
HC and MC sets of regions.  Nucleotide coverage refers to the total number of nucleotides considered 
"occupied", as a union of all called regions.  Read % generally correlates with quality of determination - 
higher is better, although the exact fraction depends in large part on the stringency of peak calling.  
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Figure 2.2.  Distribution of myogenin-occupied regions relative to nearest annotated TSS.  Distance was 
measured by taking the absolute difference between the coordinate of the region peak (as defined by 
ERANGE) and the coordinate of the TSS. 
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Figure 2.3.  A) Classification of gene models by expression profile in C2C12s.  All 31,680 RefSeq gene 
models used for RNASeq data processing were considered.  The five classes are defined as follows:  
Muscle up (5x): genes for which (expression myocytes) / (expression myoblasts) ≥ 5 and (expression 
myocytes) ≥ 1 rpkm; Muscle down (5x):  genes for which (expression myocytes) / (expression myoblasts) 
≤ 0.2 and (expression myoblasts) ≥ 1 rpkm;  Flat expressed:  genes for which 2 ≤ (expression myocytes) / 
(expression myoblasts) ≤ 0.5 and (expression myocytes) ≥ 1 rpkm and (expression myoblasts) ≥ 1 rpkm; 
Not expressed:  genes for which (expression myoblasts) ≤ 0.5 rpkm and (expression myocytes) ≤ 0.5 
rpkm; Wobbly (undetermined):  genes that do not belong to any of the first 4 categories. 
B) Expression profiles of genes with an associated myogenin-occupied region (N = 7240).  
C) Incidence of myogenin occupancy as a function of expression profile  Over two-thirds of muscle up 
genes have at least one associated myogenin region, compared to only one in six unexpressed genes. 
D) Region-centric association of myogenin occupancy and gene expression profiles. 
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Figure 2.4.  Genes whose RNA levels are up-regulated five-fold or more during differentiation have more 
regions of myogenin occupancy associated with them (by near-neighbor proximity) than do either 
down-regulated or constantly expressed genes (p < 0.0001).  This positive correlation hinges on the 
criterion of substantial upregulation upon differentiation, not on overall transcript abundance, which is 
not significant. 
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Motif Myogenin Randomized 
CAGSTG 87.0% 42.6% 
CAGCTG 75.4% 21.8% 
CAGGTG 45.0% 28.0% 
RRCAGSTG 76.0% 20.0% 
RRCAGCTG 63.9% 11.9% 
RRCAGGTG 27.6% 9.5% 
CACGTG 9.2% 5.2% 
AP-1 15.1% 9.0% 
Mef2 (half-site) 16.9% 33.0% 
Mef2 (lit) 1.5% 1.3% 
Klf4 29.1% 10.4% 
CTCF 5.7% 1.5% 
Usf1 1.7% 0.7% 
CGCGCG 5.9% 0.7% 
TATA-box 10.2% 32.8% 
Sp-1 23.9% 6.4% 
 
Table 2.5.  Coverage of myogenin ChIPSeq regions (C2C12, 60 hr after differentiation) by select motifs.  
Coverage is defined as the fraction of regions containing one or more copies of the motif.  100% 
coverage means every region has at least one copy of the motif within its boundaries, 0% means the 
union of all regions in the set is completely devoid of the motif.  For comparison, a set of approximately 
101,000 regions of the same length (501 bp) was selected at random from the genome, with provisions 
to avoid poorly sequenced areas, telomere/centromere repeats, and areas of highly repetitive sequence 
(see Methods).  Coverage of these randomized regions was computed and is provided for comparison. 
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Motif All Muscle-up Muscle-dn Flat expr. Unexpr. Random 
CAGCTG 2.55 2.49 2.44 2.47 2.57 0.29 
CACCTG 1.08 1.20 1.15 1.03 1.21 0.23 
CAGSTG 1.86 1.87 1.82 1.80 1.93 0.26 
RRCAGSTG 2.78 2.80 2.66 2.66 2.79 0.27 
RRCAGCTG 3.16 3.13 3.03 3.04 3.14 0.29 
RRCAGGTG 1.97 2.13 1.88 1.87 2.08 0.24 
CACGTG 1.02 0.72 1.11 1.17 1.03 0.15 
Meis 0.77 0.82 0.68 0.64 0.73 0.20 
AP-1 0.97 0.70 0.46 0.55 0.88 0.11 
Mef2 (half) -1.20 -1.16 -1.76 -1.56 -1.32 -0.07 
Mef2 (hybrid) 0.19 0.67 0.15 0.67 0.55 0.13 
Runx 1.06 0.97 0.97 0.87 1.02 0.21 
RP58 -0.22 -0.54 -0.25 -0.44 -0.31 0.13 
CTCF 2.42 2.76 3.54 3.05 2.89 0.46 
Mef2 (lit) 0.22 0.99 -0.30 -0.12 0.08 -0.01 
Klf4 1.89 2.18 2.29 2.26 2.11 0.20 
Usf1 1.56 1.05 1.52 2.05 2.04 0.12 
CGCGCG 3.37 3.08 4.45 4.35 3.79 -0.04 
TATA-box -2.36 -2.57 -2.75 -2.75 -2.30 -0.26 
Sp-1 2.80 2.88 3.72 3.54 3.08 0.42 
Dec1 1.03 0.43 1.68 1.40 1.11 0.13 
 
Figure 2.6a.  Comparative sequence content analysis of all myogenin-occupied regions, and groups of 
regions associated with genes of a particular expression category (and within ± 20KB of nearest TSS).  All 
= all myogenin regions (n = 14786); Muscle-up = regions associated with muscle-up genes (n = 1097); 
Muscle-dn = regions associated with muscle-down regions (n = 370); Flat expr. = regions associated with 
flat expressed genes (n = 3746); Unexpr. = regions associated with unexpressed genes (n = 2702); 
Random = randomized regions (n ≈ 101000).  Enrichment is given as log2 of (observed density) / 
(expected density), values that are not significantly different from background (p > 0.01) are displayed in 
grey, negative values represent depletion of the associated motif. 
Mef2 (lit) = canonical Mef2 motif CTAWWWWTAG. 
Mef2 (half) = half site motif AAATAG used by Cao et al. (2010). 
Mef2 (hybrid) = Mef2-associated motif GGRANHYGTAGT derived from a subset of Mef2-occupied 
regions (see chapter 3). 
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Motif all 0 - 500 501 - 2.5K 2.5K - 20K 20K+ random 
CAGCTG 2.55 2.11 2.59 2.56 2.59 0.29 
CACCTG 1.08 0.95 1.04 1.13 1.06 0.23 
CAGSTG 1.86 1.54 1.88 1.89 1.88 0.26 
RRCAGSTG 2.78 2.36 2.72 2.78 2.81 0.27 
RRCAGCTG 3.16 2.67 3.13 3.14 3.21 0.29 
RRCAGGTG 1.97 1.76 1.82 2.03 1.98 0.24 
CACGTG 1.02 1.62 1.23 0.86 0.90 0.15 
Meis 0.77 0.29 0.68 0.80 0.84 0.20 
AP-1 0.97 -0.40 0.77 0.93 1.20 0.11 
Mef2 (half) -1.20 -1.97 -1.58 -1.23 -0.99 -0.07 
Mef2 (hybrid) 0.19 1.48 0.12 0.06 -0.25 0.13 
Runx 1.06 0.38 0.79 1.12 1.18 0.21 
RP58 -0.22 -1.70 -0.14 -0.18 -0.05 0.13 
CTCF 2.42 4.14 3.00 2.09 1.41 0.46 
Mef2 (lit) 0.22 -0.32 0.16 0.30 0.27 -0.01 
Klf4 1.89 2.91 2.30 1.81 1.41 0.20 
Usf1 1.56 3.08 1.02 1.42 1.01 0.12 
CGCGCG 3.37 5.79 4.20 1.91 1.39 -0.04 
TATA-box -2.36 -3.55 -2.53 -2.36 -2.15 -0.26 
Sp-1 2.80 4.83 3.35 2.03 1.67 0.42 
Dec1 1.03 2.16 0.77 0.73 0.85 0.13 
 
Figure 2.6b.  Comparative sequence content analysis of all myogenin-occupied regions, and groups of 
regions classified by distance from nearest TSS.  All = all myogenin regions (n = 14786); 0 - 500 = regions 
with a TSS 0 - 500 bp away from peak (n = 1597); 501 - 2.5K = regions with a TSS 501 - 2500 bp away 
from peak (n = 1273); 2.5K - 20K = regions with a TSS 2501 - 20000 bp away from peak (n = 5118); 20K+ 
= regions with a TSS 20001 bp or more away from peak (n = 6798); Random = randomized regions (n ≈ 
101000).  Enrichment is given as log2 of (observed density) / (expected density), values that are not 
significantly different from background (p > 0.01) are displayed in grey, negative values represent 
depletion of the associated motif. 
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-250 
    
0 
   
250 
RRCAGSTG 0.57 0.88 1.27 2.24 4.50 4.56 2.19 1.26 0.92 0.61 
RRCAGCTG 0.55 0.94 1.43 2.55 4.94 5.02 2.51 1.44 1.08 0.66 
RRCAGGTG 0.59 0.80 1.03 1.63 3.49 3.51 1.54 0.95 0.66 0.53 
CAGCTG 0.50 0.89 1.18 2.10 4.22 4.28 2.05 1.17 0.95 0.61 
CAGGTG 0.28 0.45 0.54 0.87 2.20 2.24 0.75 0.51 0.46 0.40 
 
Figure 2.6c.  Both CAGSTG and RRCAGSTG motifs show a central enrichment tendency in the ± 50 bp 
radius from the called peak of a myogenin-occupied region.  Enrichment is given as log2 of (observed 
density) / (expected density), all values are significantly different from background (p < 0.01). 
Motif All Muscle-up 
Muscle-
dwn Flat expr. Unexpr. Random 
CAGCTG 2.55 2.49 2.44 2.47 2.57 0.29 
CAGGTG 1.08 1.20 1.15 1.03 1.21 0.23 
CACGTG 1.02 0.72 1.11 1.17 1.03 0.15 
CATATG -1.34 -1.63 -1.93 -1.81 -1.58 -0.12 
CAAATG -0.67 -0.93 -1.19 -1.07 -0.88 0.05 
CAATTG -1.16 -0.98 -1.44 -1.40 -1.45 0.01 
CAGATG 0.26 0.17 0.09 0.02 0.19 0.18 
CAAGTG 0.11 0.13 -0.16 -0.08 0.04 0.11 
CACATG -0.15 -0.29 -0.53 -0.43 -0.35 -0.02 
CAACTG 0.29 0.28 0.29 0.07 0.19 0.12 
 
Motif All 0 - 500 501 - 2.5K 2.5K - 20K 20K+ Random 
CAGCTG 2.55 2.11 2.59 2.56 2.59 0.29 
CAGGTG 1.08 0.95 1.04 1.13 1.06 0.23 
CACGTG 1.02 1.62 1.23 0.86 0.90 0.15 
CATATG -1.34 -2.94 -1.93 -1.34 -1.04 -0.12 
CAAATG -0.67 -1.92 -0.91 -0.74 -0.41 0.05 
CAATTG -1.16 -1.61 -1.45 -1.32 -0.93 0.01 
CAGATG 0.26 -0.90 0.13 0.30 0.43 0.18 
CAAGTG 0.11 -0.67 -0.04 0.12 0.26 0.11 
CACATG -0.15 -1.85 -0.45 -0.13 0.10 -0.02 
CAACTG 0.29 -0.37 0.26 0.31 0.41 0.12 
 
Figure 2.6d.  E-box motifs in myogenin-occupied regions.  Top panel same as 2.6a, bottom panel same 
as 2.6b, but only for the 10 possible e-box motifs. Enrichment is given as log2 of (observed density) / 
(expected density), values that are not significantly different from background (p > 0.01) are displayed in 
grey, negative values represent depletion of the associated motif. 
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Figure 2.7a.  Fraction of regions with multiple RRCAGSTG motifs in myogenin-occupied regions grouped 
by ChIPSeq signal strength. 
 
 
Figure 2.7b.  Fraction of regions with multiple AP-1 motifs (TGAGTCA) in myogenin-occupied regions 
grouped by ChIPSeq signal strength. 
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Figure 2.8.  ChIPSeq signal strength for each myogenin-occupied region was correlated with transcript 
abundance of the associated gene.  There is no correlation for either the set of all HC regions (blue, 
R=0.052) or the set of regions with ChIPSeq signal strength above 90th percentile (red, R=0.014). 
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Motif -2500 
    
0 
   
2500 
CAGCTG 0.14 0.18 0.17 0.16 0.32 0.75 0.40 0.30 0.27 0.25 
CACCTG 0.15 0.19 0.17 0.15 0.20 0.48 0.36 0.24 0.26 0.25 
CAGSTG 0.15 0.18 0.17 0.15 0.25 0.59 0.37 0.26 0.27 0.25 
RRCAGSTG 0.18 0.26 0.25 0.22 0.28 0.74 0.49 0.36 0.32 0.32 
RRCAGCTG 0.12 0.22 0.19 0.17 0.33 0.89 0.50 0.36 0.31 0.30 
RRCAGGTG 0.24 0.30 0.31 0.28 0.22 0.54 0.47 0.36 0.33 0.35 
CACGTG 0.11 0.15 0.26 0.40 0.95 0.50 0.45 0.28 0.22 0.17 
CATATG -0.20 -0.15 -0.20 -0.32 -0.73 -1.22 -0.59 -0.36 -0.25 -0.28 
CAAATG -0.17 -0.17 -0.17 -0.23 -0.54 -0.85 -0.40 -0.24 -0.18 -0.18 
CAATTG -0.19 -0.12 -0.22 -0.20 -0.31 -0.93 -0.41 -0.20 -0.22 -0.34 
CAGATG 0.01 0.01 -0.03 -0.15 -0.31 -0.12 -0.08 -0.06 -0.05 -0.01 
CAAGTG 0.16 0.18 0.12 0.10 -0.07 -0.20 0.00 0.13 0.14 0.19 
CACATG 0.02 0.00 -0.02 -0.20 -0.56 -0.99 -0.46 -0.21 -0.09 -0.08 
CAACTG 0.06 0.03 0.03 -0.01 -0.12 -0.14 0.02 0.03 0.05 0.04 
Meis 0.03 0.05 0.02 0.01 0.08 0.33 0.20 0.12 0.11 0.14 
AP-1 0.10 0.10 0.10 0.06 0.01 -0.46 -0.21 0.00 0.09 0.12 
Mef2 (half) -0.19 -0.14 -0.12 -0.14 -0.42 -1.05 -0.43 -0.23 -0.19 -0.17 
Mef2 (hybrid) -0.05 0.07 0.28 0.29 1.67 0.40 0.11 0.23 0.22 0.01 
Runx 0.05 0.07 0.05 -0.01 0.08 0.52 0.38 0.25 0.18 0.20 
RP58 -0.09 -0.07 -0.12 -0.21 -0.48 -0.38 -0.24 -0.18 -0.12 -0.09 
CTCF 0.69 0.66 0.83 1.27 2.92 2.76 1.62 0.99 0.66 0.68 
CACACA 0.08 0.07 0.08 0.01 -0.53 -1.07 -0.39 -0.05 0.01 -0.02 
Mef2 (lit) -0.19 -0.16 -0.08 -0.16 -0.28 -1.59 -0.53 -0.12 -0.21 -0.25 
Klf4 0.43 0.48 0.60 0.93 2.28 1.42 1.03 0.71 0.63 0.54 
Usf1 0.10 0.21 0.21 0.44 2.55 0.97 0.54 0.36 0.18 0.24 
CGCGCG 0.31 0.52 1.09 2.00 4.17 4.31 2.45 1.38 0.72 0.49 
TATA-box -0.23 -0.28 -0.24 -0.20 -0.80 -1.98 -0.78 -0.33 -0.37 -0.25 
 
Figure 2.9a.  Mapping motifs in a 2500 bp radius around TSSes of all 31680 gene models used for the 
RNASeq determination in C2C12s.  Mapping was adjusted for directionality of the associated ORF - 
notice the sharp enrichment gradients around the TSS (position 0) for some of the motifs.  Each cell 
represents a 500 bp "step".  Enrichment values computed that same way as above. 
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Figure 2.9b.  Same as 2.9a, except using a 250 bp radius; each cell represents a 50 bp "step". 
  
Motif -250 
    
0 
   
250 
CAGCTG 0.07 0.35 0.46 0.43 0.81 1.12 0.93 0.76 0.71 0.72 
CACCTG 0.08 0.22 0.16 0.23 0.11 0.33 0.52 0.52 0.58 0.41 
CAGSTG 0.08 0.27 0.27 0.31 0.40 0.67 0.68 0.61 0.63 0.53 
RRCAGSTG 0.08 0.39 0.30 0.36 0.61 0.81 0.87 0.80 0.81 0.71 
RRCAGCTG 0.03 0.42 0.34 0.45 0.96 1.17 1.08 0.96 0.94 0.88 
RRCAGGTG 0.15 0.34 0.26 0.25 0.08 0.25 0.57 0.58 0.65 0.49 
CACGTG 0.60 1.00 1.15 1.44 1.60 0.78 0.42 0.31 0.38 0.50 
CATATG -0.74 -0.77 -1.12 -1.16 -1.46 -1.72 -1.96 -1.74 -1.40 -1.33 
CAAATG -0.52 -0.63 -0.57 -0.86 -1.06 -1.18 -1.19 -1.23 -0.92 -0.91 
CAATTG -0.36 -0.42 -0.46 -0.25 -0.96 -1.17 -1.10 -1.17 -0.96 -0.88 
CAGATG -0.40 -0.41 -0.32 -0.50 -0.49 -0.38 -0.21 -0.29 -0.24 -0.16 
CAAGTG -0.15 -0.11 -0.18 -0.30 -0.39 -0.46 -0.34 -0.39 -0.29 -0.20 
CACATG -0.60 -0.62 -0.66 -0.70 -1.09 -1.14 -1.26 -1.12 -1.17 -1.02 
CAACTG -0.20 -0.15 -0.22 -0.06 -0.15 0.15 -0.18 -0.27 -0.35 -0.31 
Meis 0.06 0.03 0.10 0.14 0.18 0.48 0.34 0.28 0.18 0.31 
AP-1 -0.20 -0.18 0.34 -0.06 -0.17 -0.52 -0.63 -0.77 -0.47 -0.76 
Mef2 (half) -0.51 -0.54 -0.59 -0.65 -0.69 -1.87 -1.32 -1.34 -1.05 -1.31 
Mef2 (hybrid) 1.19 1.93 2.20 2.77 1.86 0.46 0.13 0.22 0.35 0.70 
Runx 0.06 0.20 0.07 0.18 0.06 0.82 0.67 0.61 0.49 0.47 
RP58 -0.67 -0.71 -0.63 -0.69 -0.75 -0.79 -0.73 -0.90 -0.66 -0.23 
CTCF 2.56 3.06 3.55 3.97 3.43 2.88 2.74 2.77 2.90 2.51 
CACACA -0.68 -0.60 -0.93 -0.96 -1.38 -1.65 -1.83 -1.39 -1.18 -1.26 
Mef2 (reference) -0.86 -0.25 -0.41 0.06 -0.16 -2.79 -2.11 -1.11 -1.94 -2.79 
Klf4 1.84 2.25 2.73 3.32 3.05 1.07 1.21 1.36 1.52 1.63 
Usf1 1.78 2.30 2.94 3.64 4.00 2.00 1.17 0.75 0.17 1.21 
CGCGCG 3.56 4.09 4.51 4.97 5.11 4.78 4.36 4.29 4.23 4.32 
TATA-box -0.89 -0.98 -1.11 -1.23 -0.97 -3.03 -2.85 -2.45 -2.34 -1.98 
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Chapter 3:  Comparative occupancy analysis of transcription factors active 
during myogenesis. 
 
3.1 Introduction: joint occupancy versus exclusive occupancy 
 
Having examined the myogenin occupancy map in differentiating C2C12s and its properties, a natural 
next step was to compare it to other transcription factors important to muscle differentiation.  A 
number of questions, both empirical and conceptual, could be addressed by a cross-comparison of 
occupancy data, several of which will be discussed in this chapter.  First, an analysis of transcriptional 
regulation of myogenesis would not be complete without consideration for MyoD, and section 3.2 was 
dedicated to the comparison between myogenin and MyoD occupancy, as well as differential occupancy 
by MyoD in cycling myoblasts.  The latter provided motif-level evidence for collaboration between MyoD 
and AP-1 (also noted by Cao et al. 2010), which was further studied in section 3.3 by determining and 
analyzing a Fosl1 occupancy map in cycling C2C12 myoblasts. 
Several hypotheses existed regarding the spatial relationship between Mef2 and MRF occupancy (based 
on functional studies of active promoter/enhancer elements), and about Mef2 targeting mechanisms 
(Molkentin el al.  1995).  With Mef2 being the primary non-bHLH transcription factor associated with 
regulation of myogenesis, testing them was a high priority.  To that effect, Mef2 occupancy in 
differentiating myocytes was determined, analyzed for sequence content, and compared to myogenin - 
these results are presented in section 3.4. 
Finally, I will consider two transcription factors that are not considered to have a direct role in skeletal 
muscle specification, but that are both present and active in C2C12 cells.  One is CTCF, whose 
recognition motif was enriched in several MRF measurements.  CTCF itself is an important regulatory 
factor that fulfills a variety of roles, hence its occupancy in relation to myogenin and MyoD will be 
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evaluated (section 3.5).  The other is Usf1 - a c-myc-like bHLH transcription factor associated with a set 
of Mef2-occupied regions.  While Usf1 is believed to be a "housekeeping" transcription factor, its 
association with Mef2 prompted a closer look (section 3.6).   
The analysis focused heavily on sequence content of occupied regions.  It also focused on identifying 
joint and differential occupancy by the various TFs, and on characterizing its properties.  Region-gene 
associations and distance distribution from nearest annotated TSS were also measured to gain a sense 
of the overall network architecture. 
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3.2 Myogenin and MyoD occupancy in differentiating myocytes is highly concordant 
 
Both MyoD and myogenin mRNAs are highly abundant in differentiating C2C12 myocytes (Table 3.7), 
with myogenin  transcript approaching structural protein levels 60 hours after withdrawal of serum.  The 
two factors are closely related by sequence homology, yet function in different stages of the 
differentiation process, and there is no readily available compensator for the absence of myogenin, 
which leads to a failure of muscle fiber maturation (see Introduction).  An important question for 
understanding the transcriptional network of skeletal muscle differentiation was to quantify the extent 
to which MyoD and myogenin occupy the same DNA elements, as well as to identify and examine any 
apparent differences. 
MyoD occupancy was measured in C2C12s using a monoclonal antibody and the same protocol as that 
for myogenin (Kwan, unpublished).  Unlike myogenin, MyoD is present both in the myoblast and the 
myocyte stages, hence occupancy was measured in cycling myoblasts and in differentiating myocytes at 
24 and 60 hours after withdrawal of serum, with primary region calling results summarized in Table 3.1a.  
The occupancy maps were compared to identify preferential state-specific occupancy, if any.  The 60 hr 
measurement was particularly successful, and almost fully encompassed the 24 hr determination.  Of 
the 9922 HC MyoD 24h regions, 8828 (89.0%) overlapped a MyoD 60h HC region, with the fraction 
increasing to 93.4% (9269) when compared to MyoD 60h MC regions instead (Table 3.3a).  In light of 
this, I will at times refer to the 60 hr set of MyoD regions as representative of occupancy in 
differentiating cells.  The 24 hr dataset proved useful for computing differential occupancy, due to the 
smaller number of sites identified in cycling cells. 
To answer the question of shared occupancy, maps for MyoD and myogenin at the 60 hr timepoint were 
compared.  There were 14798 HC myogenin regions and 16460 HC MyoD regions at 60 hr after 
differentiation, with 12904 (87.2%) myogenin HC regions overlapping MyoD MC (Table 3.3a).  Only 1257 
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myogenin regions (8.5%) were completely disjoint from a MyoD-occupied site (Table 3.3b).  The same is 
true in reverse - 82.3% of MyoD 60 hr regions are shared with myogenin, and only 2088 out of 16460 
(12.7%) are completely disjoint.  Using the MyoD 24 hr dataset yielded a similarly high degree of overlap 
(Table 3.3).  Essentially, MyoD and myogenin occupy the same loci in differentiating myocytes - at least 
four out of every five elements displaying a MyoD signature also display one for myogenin, and vice 
versa.  This degree of overlap is remarkable because it is comparable to biological replicates, even 
though the antibodies used for MyoD and myogenin have been tested extensively, and they do not 
cross-react. 
The situation changed somewhat when MyoD occupancy in cycling myoblasts was examined.  Of the 
6651 HC MyoD cycling regions, 3661 (55.0%) overlapped myogenin HC, and 4709 (70.1%) overlapped 
myogenin MC regions (Table 3.3).  While the similarity is still substantial, these results point to changes 
in the occupancy profile of MyoD upon cell cycle exit and initiation of terminal differentiation.  To 
further define differential occupancy by MyoD, three sub-groups of regions were selected:  those only 
occupied in cycling progenitor cells ("early" sites), those occupied only in differentiating myocytes ("late" 
sites), and those occupied in both states ("continuous" sites).  The set of "late" sites consisted of 2716 
regions, of which 2348 (86.5%) overlapped myogenin MC regions.  The remaining 13.5% failed to 
manifest any readily observable properties that would make them stand out for further study.  The 
"late" MyoD regions also had the highest coverage by the RRCAGSTG motif, at 84.8% (Table 3.8c).  There 
were, 3515 "continuous" regions of MyoD occupancy, defined as sites that had a HC signal in both the 
cycling and the 60 hr differentiated cells.  Of them, 2689 (76.5%) overlapped myogenin MC regions.  The 
653 that did not were examined separately as "continuous exclusive" sites, and will be referred to when 
sequence content is discussed.  Finally, there were 951 "early" MyoD sites - those occupied in cycling 
myoblasts but not in differentiating cells.  Only 5 "early" sites overlapped myogenin HC regions, with 29 
further included when using myogenin MC instead; 903 (95.0%) "early" sites were completely disjoint 
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from myogenin.  This led to the conclusion that the primary difference between MyoD and myogenin 
lies in the sites that MyoD occupies exclusively in cycling cells - once terminal differentiation begins, the 
two factors occupy virtually identical sets of elements, although subtle differences do exist. 
Sequence content analysis was performed on the four base ChIPSeq determinations (MyoD cycling, 
MyoD 24h, MyoD 60h, myogenin), the four sub-groups of differentially occupied MyoD regions 
discussed above, and two additional sub-groups - sites unique to either MyoD or myogenin at the 60 hr 
timepoint.  It consisted of de novo motif discovery using MEME and extensive mapping of known 
matrices, with the de novo analysis deriving an extended version of the AP-1 recognition site 
(TGASTCACW) when presented with "early" MyoD regions.  The results of sequence content analysis are 
summarized in Figure 3.4a.  The motif RRCAGSTG showed a strong central enrichment tendency in all 4 
primary datasets (Figure 3.4b) and also covered a majority of the regions (Table 3.8a).  The "early" MyoD 
regions clearly stood out from the other differentially occupied sub-groups, showing a significant 
difference in motif content (p < 0.01) for a variety of sites, including the primary recognition motif 
RRCAGSTG, AP-1, RP58 and Klf4 (Figure 3.5).  Over half of the "early" regions contain at least one AP-1 
motif (Table 3.8c).  The frequency of RRCAGSTG was greatly diminished, with only 41% coverage, 
compared to 84.8% for the "late" set (Table 3.8c).  Furthermore, 60% of the regions with an RRCAGSTG 
motif also contained the AP-1 site.  This is in sharp contrast with the "late" MyoD regions, where the AP-
1 motif is significantly (p < 0.01) depleted (Figure 3.5).  The other MyoD region groupings were well 
covered by RRCAGSTG (Table 3.8c).  Notably, MyoD-exclusive regions had an almost even split between 
RRCAGCTG and RRCAGGTG motifs, while myogenin-exclusive regions heavily favored the RRCAGCTG 
version, suggesting subtle targeting differences between the two MRFs. 
To identify potential differences in regulatory targets of MyoD and myogenin, region-gene association 
profiles were generated for the 3 MyoD datasets, and compared to each other and to myogenin.  The 
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normalized results (due to differing numbers of regions in each dataset) are summarized in Figure 3.2.  
The overall profiles are very similar, and some tendencies become apparent.  The vast majority of 
regions (60-70%, depending on the set) are associated with genes that are expressed in both myoblasts 
and myocytes, and whose mRNA levels do not change drastically (flat and undetermined categories).  
Together, regions associated with myoblast and myocyte genes comprise less than 15% of the total 
number of observed occupancy events.  After the onset of differentiation there is an increase in the 
frequency of "muscle up" (myocyte) associations, and myocyte associations outnumber their myoblast 
counterparts by approximately 3:1.  MyoD regions in cycling myoblasts are almost equally likely to be 
associated with either a "muscle-up" or a "muscle-down" gene, although the probability of either 
association is less than 15%.  These results are not unexpected given the high degree of similarity 
between MyoD and myogenin occupancy.   
Overall, I found that MyoD and myogenin occupy a largely shared set of sites in differentiating 
myocytes.  Both factors recognize the motif RRCAGSTG, but subtle differences exist in the distribution of 
the GC vs. GG e-box "cores".  Myogenin-occupied regions heavily favor GC over GG, while in MyoD-
occupied regions the distribution is more even (but still slanted in favor of GC).  Regions preferentially 
occupied by MyoD in cycling myoblasts are distinct from the rest, both in terms of sequence content and 
their genomic distribution relative to nearest TSS.  Their high coverage by the AP-1 motif TGAGTCA 
suggests a collaboration between MyoD and AP-1, which is investigated in section 3.3. 
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3.3  MyoD collaboration with AP-1 is limited to cycling myoblasts 
 
AP-1 (jun/fos heterodimer) was first linked to myogenesis when it was shown that Mef2a and Mef2d can 
regulate the promoter of c-Jun (Han et al. 1992; Han and Prywes 1995).  It was later proposed that AP-1 
is involved in a feed-forward loop that leads to the activation of the MRF transcription factors 
(Andreucci et al. 2002), and its recognition sequence was independently reported enriched in MyoD-
occupied regions during muscle differentiation (Cao et al. 2010).  Data discussed in the previous section 
show a strong presence of the AP-1 site in a subset of regions occupied by MyoD in cycling myoblasts 
("early" MyoD regions).  This association abates completely, on the sequence level, in "late" MyoD 
regions (those preferentially occupied in differentiating myocytes), where the AP-1 motif is depleted 
(Figure 3.5).  To better understand the nature of AP-1 action in myoblasts and its collaboration with 
MyoD, Fosl1 (also known as Fra1) occupancy was measured in cycling C2C12s (Marinov, unpublished).  
The ChIPSeq measurement gave 2261 HC regions (Table 3.1b), which I analyzed for motif content, 
overlap with MyoD, proximity to nearest TSS, and expression patterns of nearest gene. 
Motif mapping showed a strong central enrichment for the cited motif TGAGTCA, as well as for the 
alternative matrix TGASTCACW derived from early MyoD regions  by MEME (Figure 3.11a).  Given their 
similar enrichment patterns and the fact that TGAGTCA covered twice as many regions as TGASTCACW 
(70% and 35%, respectively) (Table 3.11b), the former was used as the representative Fosl1 site for the 
purposes of analysis.  When compared side-by-side to MRF-occupied regions, differences in sequence 
profiles were readily apparent (Figure 3.12).  The RRCAGSTG motif occurred at background levels, with 
no statistically significant difference from genomic density, although this was the result of a minor 
enrichment of the RRCAGCTG component and a minor depletion of RRCAGGTG (both statistically 
significant, p < 0.01).  This is consistent with lack of binding affinity between Fosl1 and RRCAGSTG.  
There was also no enrichment of CTCF or Klf4 sites, both of which occurred at background levels, and 
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there was a significant (p < 0.01) and substantial (almost threefold) depletion of the CGCGCG Set1 target 
site.  Curiously, the bias against TATA-boxes and CAWWTG class e-boxes persisted, with all species 
depleted (p < 0.01) compared to expectation (Figure 3.12).  The motif content differences became more 
pronounced when occupancy maps for Fosl1 and MyoD in cycling myoblasts were compared for overlap.  
Regions specific to Fosl1 (no overlap with MyoD MC regions) showed a significant (p < 0.01) two-fourfold 
depletion for all e-boxes of the form CAGSTG, and were depleted of every other e-box motif except 
CACGTG and CAGATG, which occurred at background levels (Figure 3.12).  Taken together with a similar 
depletion of AP-1 sites in MyoD "late" regions, these data point to a strong functional impetus for 
keeping parts of the two networks separate. 
On the other end of the spectrum, there were 215 regions of joint occupancy between the "early" MyoD 
subset and Fosl1.  The AP-1 motif covers 68.8% of the shared regions, whereas RRCAGSTG only covers 
24.2%.  Furthermore, of the 52 regions with an RRCAGSTG motif, 40 also contained an AP-1 site, leaving 
only 12 out of 215 (5.6%) that have an MRF recognition sequence without an accompanying AP-1 motif.  
When both motifs were  present, DNAse hypersensitivity footprints were more proximal to the AP-1 
motif than to the octameric e-boxes.  While there was no way to distinguish between joint occupancy 
and sample heterogeneity effects, sequence content strongly suggests that MyoD is recruited to these 
sites primarily by means of protein-protein interactions.  There was no evidence to support this 
recruitment the other way, as only 12 jointly occupied regions that contain RRCAGSTG but not 
TGAGTCA.  In comparison, "late" MyoD regions had zero overlap with Fosl1 occupancy, even when 
compared to MC-threshold regions - Fosl1 occupancy and MyoD "late" occupancy are completely 
disjoint, without even a partial overlap.  Such a strong exclusion is rather remarkable, even if consistent 
with motif content analysis - "late" MyoD sites are significantly (p < 0.01) depleted of AP-1 motifs.  The 
interaction between MyoD and Fosl1 is therefore limited to cycling myoblasts, and indeed the levels of 
Fosl1 transcript diminish by almost 90% in differentiating myocytes (Table 3.7).  This does not preclude a 
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potential interaction with Fosl2 (also known as Fra2), which is expressed in differentiating C2C12, but 
makes it less probable due to the depletion of supporting motifs.  If such an interaction were to occur, it 
would have to rely on MyoD:E binding DNA, then bringing in Fosl2 through secondary means. 
Gene association analysis of Fosl1 occupancy gave results similar to those obtained from the MRFs 
(Figure 3.6a).  There was a higher fraction of regions associated with myoblast genes (5.2%), however it 
was small compared to the total size of the dataset (Table 3.6b).  Fosl1 occupancy is likely (p < 0.01) to 
be associated with genes that are expressed, and 49.2% of Fosl1 occupied regions are associated with 
either flat or undetermined genes.  While a lower fraction than was observed for the MRFs, it still 
encompasses half of all detected Fosl1 occupancy events.  
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3.4  Understanding the role of Mef2 in the regulation of skeletal muscle differentiation 
 
Mef2 has been shown to directly regulate several genes specific to developing skeletal muscle (see 
Introduction), where functional studies suggest a positioning pattern.  Typically, Mef2-responsive 
regulatory modules contained a Mef2 A/T rich recognition site and an MRF-class e-box (CAGSTG) within 
100 - 150 nucleotides of one another.  This suggests a collaborative relationship, where the two factors 
occupy proximal sequence elements and jointly regulate the expression of the target gene.  Further 
studies showed that Mef2 is able interact in vitro with Myog:E12 heterodimers, but not myogenin or E12 
on their own (Molkentin et al. 1995); and that Myog:E12 complexes can be recruited to a sequence 
element by Mef2 even in the absence of an CAGSTG e-box, provided a Mef2 recognition site was 
present.  Consequently, Mef2 can regulate transcription of its target genes both through direct protein-
DNA binding, and through secondary recruitment by an MRF:E heterodimer.  To evaluate the relative 
prevalence of these interactions, I used a Mef2 occupancy determination in differentiating C2C12s 
(Fisher-Aylor, unpublished), which was analyzed for sequence content, gene associations, and overlap 
with the myogenin occupancy map. 
Initially, several chromatin immunoprecipitation experiments using the protocol from Mortazavi et al 
(2007) and targeting Mef2 were unsuccessful, necessitating the use of a stronger fixing agent 
(gluteraldehyde) before usable data could be collected.  Because three members of the Mef2 family are 
present in C2C12s at various stages of development (Table 3.7), a pan-Mef2 antibody was used.  
ERANGE identified 3072 HC regions occupied by Mef2 in differentiating myocytes (60 hours after 
withdrawal of serum), which were analyzed for sequence content through a combination of de novo 
motif discovery and pre-defined motif mapping, yielding some unanticipated results.  Based on the prior 
observations from myogenin, MyoD and Fosl1, I expected to a strong coverage of the dataset by the 
canonical Mef2 motif CTAWWWWTAG.  In fact, only 3.8% of Mef2 regions (Table 3.8b) contained the 
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literature site - this represents a three-fold enrichment (p < 0.01) over genomic background (Figure 
3.9a), but by itself fails to account for the vast majority of occupied regions.  Another form of the motif - 
AAATAG, used by Cao et al. (2010) in their investigation of differential MyoD occupancy, showed a 
significant (p < 0.01) depletion relative to genomic background, and consequently its coverage of the 
Mef2 occupancy map was lower than that of randomly generated regions (Table 3.8b).  De novo motif 
finding derived a version of the canonical site when presented with the list of 500 strongest occupancy 
events (organized by ChIPSeq signal associated with the event), but it was superseded in frequency and 
abundance by three other motifs.  One was the primary MRF motif RRCAGSTG, observed in 52.5% of 
Mef2-occupied regions.  Another was CACGTGAC, which based on a literature search and existing motif 
databases was attributed to Usf1 - a c-myc related member of the bHLH family that will be discussed in 
section 3.6.  The Usf1 motif was highly enriched compared to the whole genome background 
(twentyfold enrichment, p < 0.01) but only covered 9.3% of the Mef2 dataset.  The third non-canonical 
motif derived by MEME was GGGANWTGWAGT, which resembles a combination of the canonical Mef2 
and the canonical SRF motifs.  This site will be referred to as Mef2-hybrid in the analysis, and covered 
17.1% of the Mef2 regions (Table 3.10). 
The high coverage by RRCAGSTG and general lack of canonical sites in Mef2 occupancy events implied 
that most Mef2-MRF collaboration events in muscle cells are the result of protein-protein recruitment.  
An occupancy map comparison between Mef2 and myogenin produced 1834 regions with some direct 
overlap (referred to as Mef2+Myog), and 1238 regions that had Mef2 occupancy and were completely 
disjoint from myogenin regions (referred to as Mef2-Myog).  Mef2-Myog regions were highly promoter 
proximal - 840 (67.9%) were centered between -1000 and +250 from an annotated TSS; and 1034 
(83.5%) were associated with either flat (640) or undetermined (394) genes.  They showed no 
enrichment for RRCAGSTG (Figure 3.9a).  A substantial minority were covered by the Mef2-hybrid motif 
(34.5%, Table 3.10), with the central enrichment tendency typical of the primary sequence responsible 
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for the occupancy event (Figure 3.9b).  This led me to theorize that Mef2-hybrid is an alternative 
recognition sequence for Mef2, and to test it using EMSA.  There was no detectable in vitro binding 
between either Mef2a or Mef2d and the Mef2-hybrid motif, although both Mef2a:Mef2a homodimers 
and Mef2a:Mef2d heterodimers were able to bind the canonical motif CTAWWWWTAG (Figure 3.13).  
Mef2-Myog regions additionally had a thirtyfold enrichment of the Usf1 motif (p < 0.01), with the same 
central tendency as Mef2-hybrid (Figure 3.9e).  Its relatively low coverage (16.3%) and known 
association made it an unlikely candidate for direct Mef2 binding, but in turn made Usf1 a likely 
collaborating factor.   
Mef2+Myog regions closely resemble myogenin regions in terms of their motif content (Figure 3.9a).  
They have the highest incidence of the Mef2 canonical motif CTAWWWWTAG, but it only covers 4.3% of 
Mef2+Myog regions (Table 3.10).  The majority of Mef2+Myog regions are covered by RRCAGSTG 
(75.6%), which is consistent with rate of coverage for the myogenin set as a whole.  The Mef2-hybrid 
motif was also enriched (p < 0.01), but only covered 5.3% (Table 3.10).   The RRCAGSTG motifs in 
Mef2+Myog, as well as both Usf1 and Mef2-hybrid motifs in Mef2-Myog show a strong central tendency 
(Figures 3.9b-e).  The canonical motif CTAWWWWTAG first found in a number of muscle-specific 
enhancer and promoter elements does associate preferentially with genes that are heavily upregulated 
during terminal differentiation (twofold motif enrichment, p < 0.01).  This association is, however, rare, 
and a vast majority of RRCAGSTG boxes showing myogenin occupancy (>99%) do not contain such a 
motif within a 250 bp radius.   
The occupancy map of Mef2 consists of groups of regions, each featuring a different motif with the 
central tendency characteristics of a primary target, but for which Mef2 has no direct binding affinity.  
Mef2a and Mef2d do not bind either RRCAGSTG, CACGTGAC, or the "hybrid" site GGGANWTGWAGT in 
vitro.  The one motif Mef2 does bind - CTAWWWWTAG - covers only 5.3% of detected occupancy 
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events.  MRFs and Mef2 do share occupancy - 60% of detected Mef2 regions have a corresponding 
myogenin signature, and, conversely, 12% of myogenin HC regions have an overlapping Mef2 signal.  
Finally, gluteraldehyde fixation used for the Mef2 determination increases the odds of detecting 
secondary interactions when compared to paraformaldehyde.  Put together, these results show that 
Mef2 is primarily directed to its target sites through protein-protein interactions.  Direct binding by 
Mef2 is not necessary for recruitment or exertion of regulatory activity, although functional studies 
demonstrate that it leads to an increase in transcriptional output when present.  In skeletal muscle, the 
vast majority of interactions are initiated through MRF:E binding DNA, then bringing in Mef2.  There 
were no instances where a myogenin signal originated over a Mef2 canonical site in the absence of an 
accompanying RRCAGSTG, compared to 1323 instances where a Mef2 signal originating over a 
myogenin-occupied RRCAGSTG without an accompanying CTAWWWWTAG. 
Overall, Mef2 acts as a transcriptional regulator in differentiating skeletal muscle, but its targeting 
mechanism differs from that of the MRFs.  It is more limited in the number of sites it occupies and 
correspondingly in the number of genes it likely affects.  A large portion of Mef2 occupancy is directed 
at proximal promoters of genes that maintain a stable transcript level in both progenitor myoblasts and 
terminally differentiated myocytes.  This can be interpreted in two ways - Mef2 could have a strong 
"housekeeping" role, or it could be recruited to active promoters because it is available.  Both are 
plausible, and the role of Mef2 merits further investigation.  It can be further studied by mapping of 
occupancy for Mef2a, Mef2c and Mef2d explicitly, as all three are present and up-regulated in 
differentiating skeletal muscle (Mef2d is also present in cycling myoblasts), but could have different 
binding preferences or sets of targets.  Clarifying the binding preferences for various Mef2 dimers and 
functional studies that focus on the effects of secondary Mef2 presence at regulatory elements would 
also provide valuable insights.   
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3.5 CTCF-occupied sites act as insulators in differentiating skeletal muscle 
 
CTCF is an 11-Zinc finger factor that is highly conserved in most vertebrates (Filippova et al. 1996), and 
has been associated with transcriptional repression (Baniahmad et al. 1990), activation (Klenova et al. 
1993) and most prominently insulation (Bell et al. 1999).  It was first described as a regulator of c-myc in 
gallus gallus (Lobanenkov et al. 1990), but has since been ascribed a variety of functions related to  
chromatin remodeling - such as facilitation and maintenance of looping (Splinter et al. 2006).  CTCF 
message is present in both myoblasts and myocytes, although its amount diminishes over time (Table 
3.7).  A motif associated with CTCF occupancy is enriched (p < 0.01) in regions occupied by a number of 
assayed transcription factors, and although the absolute number of instances varies, the motif is 
complex enough so that even a relatively small number of occurrences can represent a statistical 
enrichment.  The consistency with which this enrichment occurs suggests an overlap between 
occupancy maps of CTCF and studied TFs.  Additionally, a CTCF occupancy map provides an immediate 
avenue to test its function as an insulator in differentiating skeletal muscle.  I used data from Mikkelsen 
(unpublished) to analyze CTCF occupancy in cycling myoblasts and in differentiating myocytes. 
The first, and primary, observation to come out of the CTCF analysis was about insulation.  When 
comparing CTCF and myogenin occupancy at 60 hrs after differentiation, CTCF regions were much more 
likely to occur between a myogenin region and a TSS of down-regulated gene than any other type of 
TSS.  The percentage of "open" connections (no CTCF occupancy between myogenin region and TSS) was 
highest for myocyte genes, somewhat lower for flat and unexpressed genes, and lowest for myoblast 
genes.  This frequency was statistically indistinguishable when comparing the flat and unexpressed sets.  
Statistical difference was highest between myocyte and myoblast sets (p < 1x10-6), although myocyte 
connections were also somewhat more likely to be open than either flat or unexpressed ones (p < 0.01) 
(Table 3.15). This behavior is consistent with insulation of active myogenin sites from "undesirable" 
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genes, e.g., those that are down-regulated upon entry into terminal differentiation.  A similar 
observation was used by Cao et al.  (2010) when associating regions of MyoD occupancy events with 
their target genes, leading support to the idea that CTCF acts as an insulator in differentiating myocytes. 
The CTCF occupancy determination itself was subjected to the same sequence content, gene association 
and overlap analyses as the other ChIPSeq datasets discussed herein.  Overview of the primary results 
for both sets of regions are summarized in Table 3.1b.  CTCF-occupied regions are among the most likely 
to be associated with unexpressed genes - nearly 40% of occupancy events in cycling myoblasts were 
associated with genes lacking measurable transcript levels (Figure 3.6a), which is consistent with CTCF's 
ability to act as both a repressor and an insulator, and leads us to expect a higher likelihood of CTCF 
occupancy associating with unexpressed or down-regulated genes.  The latter expectation, however,  
does not pan out - the fraction of associations with down-regulated genes is comparable to that for 
myogenin and other positive-acting factors (MyoD and Usf1), and did not increase between cycling and 
differentiated states.  In conjunction with the results from Table 3.15, this implies that CTCF more likely 
acts as an insulator than a direct repressor during skeletal muscle differentiation. 
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3.6 Usf1 occupancy in C2C12s suggests minimal involvement in the muscle differentiation 
network 
 
Usf1 is a bHLH transcription factor similar to c-myc by virtue of having the leucine-rich domain (Gregor 
et al. 1990), and was first isolated from HeLa cells due to its ability to activate the adenoviral major late 
promoter (MLP) (Sawadogo et al. 1988).  Like all bHLH proteins, it binds DNA in the form of a dimer, and 
can both homodimerize and heterodimerize with Usf2 (Sirito et al. 1992).  The reported recognition 
motif is the octamer CACGTGAC (Rada-Iglesias et al. 2008), although the strictness of the flanking 
nucleotides, as well as potential promiscuity in the central nucleotides, deserves further investigation.  
Usf1 originally garnered attention during the analysis of Mef2 occupancy data, where a high density of 
CACGTG hexamers and CACGTGAC octamers was discovered in the set of regions that had no overlap 
with myogenin (Figure 9a).  The latter were predominantly associated with "flat" genes (those that 
remain stably expressed both in cycling and differentiating C2C12s) , and the mRNA levels for both Usf1 
and Usf2 remain virtually constant throughout the differentiation timeline, with less than a 10% 
difference between cycling myoblasts and myocytes 7 days after onset of differentiation (Table 3.7).  
Based on the Mef2 analysis and published data, the expectation was for Usf1 to preferentially occupy 
promoters of genes whose expression remains stable throughout the differentiation process.  To put it 
another way, it has the markings of a "housekeeping" transcription factor.  To test this, as well as to 
investigate any potential role that Usf1 plays in skeletal muscle differentiation, genome-wide occupancy 
mapping was performed (Marinov, unpublished).   
Peak calling generated 3375 and 4516 regions at HC stringency for the 60 hr and cycling timepoints, 
respectively.  The two sets of regions showed remarkable concordance - of the 3375 regions occupied at 
60 hrs, 2875 were a 90%+ match to those occupied in the cycling state.  When the criteria for a match 
were relaxed to include the MC set of cycling regions, 3096/3375 were a 90%+ match by nucleotide 
overlap (see Methods) - a similarity this high was often observed in technical replicates of the same 
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experiment.  Conversely, 3856/4516 cycling HC regions matched 60h MC regions at the same 90%+ 
threshold, suggesting that the ultimate difference between the two measurements is likely due to 
experimental variation rather than a physiological change in occupancy profile.  The sites occupied by 
Usf1 remain virtually unchanged between myoblast and myocyte states. 
There is relatively little overlap between Usf1 and myogenin occupancy in differentiating myocytes (60 
hrs after withdrawal of serum).  Out of 3375 Usf1 HC regions, only 321 overlapped myogenin HC regions 
with 80%+ nucleotide identity, while 2845 (84.3%) showed no overlap at all.  When using the broader 
MC myogenin region set, 2319 Usf1 sites (68.8%) remained completely disjoint, while the number of 
overlapping regions increasing to 596.  Of those, 224 (37.6%) were within 1KB of a TSS, with the rest 
distributed over a range of distances.  Furthermore, 448 out of 596 (75.1%) such regions were 
associated with genes that fell into either the flat or the undetermined categories, as opposed to 24 
(4.0%) that were associated with differentially expressed genes (muscle-up or muscle-down).  This 
pattern was consistent with expectation. 
The canonical primary motif CACGTGAC showed a strong and central tendency in the 60 hr Usf1 dataset, 
however, only 1088 (32.2%) regions had such a motif (Table 3.8b).  The coverage increased substantially 
when the motif was relaxed to  the core hexamer form (CACGTG), adding a further 798 regions, for a 
total coverage of 1886/3375 (55.9%).  Still, this is below the primary motif coverage observed for MyoD, 
myogenin or Fosl1.  Most other motifs enriched in regions occupied by Usf1 in myocytes - Mef2 (hybrid), 
CTCF, Klf4, CGCGCG, Sp-1, were those generally found in promoters (Figure 2.9a).  Enrichment of 
CAGSTG and RRCAGSTG motifs was abolished by removing the ~600 regions jointly occupied by Usf1 and 
myogenin (Figure 3.14).  In aggregate, these data support the hypothesis that Usf1 is an active bHLH-
class transcription factor in the C2C12 system, and that it plays a role in the maintenance of overall cell 
function, but bears little direct impact on the developmental network responsible for skeletal muscle 
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differentiation.  Instead, Usf1 activates genes the need to be transcribed in both the cycling progenitors 
and the terminally differentiated myocytes. 
A couple questions merit further investigation.  First, based on the behavior of other bHLH transcription 
factors, most of which allow some variation in their recognition sites, the possibility that Usf1 has 
flexibility at both flanking nucleotide positions and the primary e-box core must be considered.  The 
obvious approach of taking Usf1 regions lacking CACGTG and running them through de novo motif 
finding failed to yield conclusive results, however, a deeper investigation of this issue could prove 
fruitful.  I theorize that some amalgam of CASSTGNN sites are actually acceptable, with affinity varying 
based on exact sequence.  This problem was partly addressed during the analysis of Usf1 and Usf2 
occupancy in humans (Rada-Iglesias et al. 2008), however the latter only confirmed CACGTGAC as the 
mostly likely optimal occupancy site, without ruling out occupancy of other, less optimal configurations.  
A more thorough statistical analysis of occupied motifs or in vitro protein-DNA binding experiments are 
logical next steps in determining the range of binding preferences for Usf1/2.  Second, because Usf1 
associates with active promoters, likely to harbor large regulatory complexes, the prevalence of Usf1 
occupancy from secondary interactions should also be considered.  Distinguishing between primary and 
secondary Usf1 sites could lead to a finer understanding of its function, its partners, and its targeting. 
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Figures and Tables (chapter 3) 
 
 
MyoD cycling MyoD 24h diff MyoD 60h diff 
Number of regions (HC) 6,651 9,922 16,437 
Number of regions (MC) 11,790 18,844 30,287 
Nucleotide coverage (HC) 4,092,025 3,399,686 5,473,031 
Read % in regions (HC) 7.74% 10.72% 22.45% 
Average region length (HC) 616 343 333 
Median region length (HC) 561 320 300 
Length standard deviation (HC) 247 111 139 
Minimum length (HC) 164 110 103 
Maximum length (HC) 2,786 1,403 1,687 
 
Table 3.1a.  Primary statistics for MyoD occupancy measurements.  HC = high confidence, MC = medium 
confidence.  The stringency settings for HC vs. MC were consistent across all data sets, and as a result 
most exhibited the property of having approximately 2x more MC regions.  To limit false positives, 
primary sequence and gene association analysis was focused on HC regions.  However, when evaluating 
differential occupancy, HC regions were filtered using the MC set from the other time point, and only 
those without a match were declared differentially occupied. Nucleotide coverage refers to total 
number of nucleotides covered by regions as called, giving a rough estimate of the portion of the 
genome associated with factor occupancy.  Read % in regions is a quality control metric, and refers to 
the total number of sequenced reads that fall within enriched areas.  Higher ratios are desirable, 
although usable data was obtained from experiments with as few as 1% of reads falling into enriched 
areas.   
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Fosl1 Mef2 CTCF c CTCF m Usf1 c Usf1 m 
Number of regions (HC) 2,261 3,072 21,236 14,351 4,516 3,373 
Number of regions (MC) 6,269 11,179 29,036 22,381 9,002 7,149 
Nucleotide coverage (HC) 851,347 1,247,555 7,338,588 4,448,579 2,295,114 1,501,411 
Read % in regions (HC) 2.67% 3.10% 20.88% 12.23% 11.26% 9.19% 
Average region length (HC) 377 406 346 310 508 445 
Median region length (HC) 366 368 329 288 468 397 
Length std. deviation (HC) 94 171 111 107 257 242 
Minimum length (HC) 78 60 89 102 104 103 
Maximum length (HC) 892 1,486 1,970 1,854 10,628 4,641 
 
Table 3.1b.  Primary statistics for ChIPSeq occupancy measurements for Fosl1, Mef2, CTCF and Usf1.  HC 
= high confidence, MC = medium confidence.  CTCF c and Usf1 c were done in cycling myoblasts. CTCF m 
and Usf1 m were done in myocytes - 60 hours after withdrawal of serum for Usf1 and 7 days after 
withdrawal of serum for CTCF.  Nucleotide coverage refers to total number of nucleotides covered by 
regions as called, giving a rough estimate of the portion of the genome associated with factor 
occupancy.  Read % in regions is a quality control metric, and refers to the total number of sequenced 
reads that fall within enriched areas.  Higher ratios are desirable, although usable data was obtained 
from experiments with as few as 1% of reads falling into enriched areas. 
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Figure 3.2.  Association between MyoD-occupied regions and their nearest gene, organized by 
expression category of the gene.  Fraction of regions associated with myocyte genes increases upon 
differentiation, while the opposite is true of the associations with myoblast genes.  The majority of 
regions in each dataset (60-70%) are associated with expressed genes whose mRNA levels do not change 
drastically (flat and wobbly categories).  The total number of regions associated with radically changing 
genes is <15%. 
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MyoD cycling MyoD 24h MyoD 60h Myogenin 
MyoD cycling - 70.8% 71.7% 52.5% 
MyoD 24h 52.2% - 93.4% 80.9% 
MyoD 60h 35.5% 78.5% - 82.3% 
Myogenin 29.1% 71.5% 87.2% - 
 
Table 3.3a. Region overlap between respective datasets.  Regions were length-normalized to ±250 bp 
around the summit, comparison was done by requiring an 80%+ coordinate overlap between a region in 
the source HC set (horizontal) compared to one from the target MC set (vertical).  HC to MC comparison 
was performed to limit the number of false negatives.  Note that some negatives will inevitably arise if 
the source set is larger than the target set, as the excess regions will have no match by definition.  Such 
comparisons are italicized, and it is a known limitation of ChIPSeq data. 
 
MyoD cycling MyoD 24h MyoD 60h Myogenin 
MyoD cycling - 1,760 1,630 2,812 
MyoD 24h 4,474 - 364 1,413 
MyoD 60h 10,197 3,085 - 2,088 
Myogenin 10,067 3,682 1,257 - 
 
Table 3.3b. Absolute number of HC regions without a match to the target MC set.  Comparisons where 
the source set is larger than the target set are italicized. 
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Myog MyoD cyc MyoD 24h MyoD 60h 
Motif 
    RRCAGSTG 2.78 2.54 2.96 2.74 
RRCAGCTG 3.16 2.95 3.34 3.04 
RRCAGGTG 1.97 1.67 2.19 2.18 
CACGTG 1.02 0.51 0.73 1.01 
CATATG -1.34 -0.80 -1.08 -1.28 
CAAATG -0.67 -0.42 -0.56 -0.72 
CAATTG -1.16 -0.69 -0.96 -1.12 
CAGATG 0.26 0.42 0.42 0.25 
CAAGTG 0.11 0.01 0.17 0.04 
CACATG -0.15 -0.16 -0.09 -0.19 
CAACTG 0.29 0.20 0.29 0.19 
Meis 0.77 0.65 0.84 0.76 
AP-1 0.97 2.34 1.14 1.03 
Mef2 (half) -1.20 -0.91 -1.08 -1.19 
Runx 1.06 1.02 0.98 0.93 
RP58 -0.22 0.40 0.08 -0.19 
CTCF 2.42 0.78 1.74 2.65 
Mef2  (lit) 0.22 -0.36 0.07 0.10 
Klf4  - GGGYGKGG 1.89 0.99 1.49 1.85 
CGCGCG 3.37 0.04 2.05 3.71 
TATA-box -2.36 -1.71 -2.06 -2.22 
Sp-1 2.80 1.21 2.09 2.95 
Dec1 - KCACGTGM 1.03 0.29 0.51 1.14 
 
Figure 3.4a.  Comparative motif enrichment analysis for MyoD and myogenin regions.  Enrichments are 
computed over genomic background, and normalized using log2.  Ratios that do not pass a statistical 
significance test (p > 0.01) are displayed in grey. 
 
-250 
    
0 
   
250 
MyoD cycing 0.49 0.64 1.03 1.52 4.35 4.43 1.55 1.04 0.88 0.40 
MyoD 24h 0.68 1.04 1.62 2.17 4.74 4.79 2.08 1.56 1.13 0.74 
MyoD 60h 0.54 0.73 1.40 1.90 4.53 4.56 1.84 1.31 0.74 0.59 
Myogenin 0.57 0.88 1.27 2.24 4.50 4.56 2.19 1.26 0.92 0.61 
 
Figure 3.4b.  The motif RRCAGSTG is highly centrally enriched in all MyoD and myogenin occupied 
regions.  Enrichment values are normalized using log2, every ratio in this example is significantly 
different from genomic background (p < 0.01).   
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early cont. late cont. ex. MyoD ex. Myog ex. 
Motif 
      RRCAGSTG 1.31 2.81 3.16 2.35 2.31 2.41 
RRCAGCTG 1.50 3.24 3.48 2.67 2.35 2.87 
RRCAGGTG 1.00 1.85 2.53 1.71 2.25 1.32 
CACGTG 0.07 0.68 0.56 0.12 0.65 0.78 
CATATG -0.48 -0.94 -1.02 -0.72 -1.06 -1.52 
CAAATG -0.39 -0.46 -0.40 -0.30 -0.60 -0.67 
CAATTG -0.61 -0.85 -0.97 -0.87 -0.91 -1.54 
CAGATG 0.41 0.42 0.47 0.51 0.29 0.24 
CAAGTG -0.01 0.11 0.27 -0.02 -0.10 0.08 
CACATG -0.16 -0.11 0.09 -0.29 -0.25 -0.38 
CAACTG 0.17 0.25 0.62 0.11 0.07 0.37 
Meis 0.22 0.78 0.93 0.66 0.67 0.61 
AP-1 2.99 1.94 -0.78 1.82 1.12 0.65 
Mef2 (half) -0.74 -1.00 -1.00 -0.62 -0.81 -1.26 
Runx 0.73 1.11 0.84 0.60 0.50 1.00 
RP58 0.79 0.27 -0.20 0.66 -0.04 -0.03 
CTCF -1.50 1.24 0.69 0.20 2.12 2.68 
Mef2 (lit) -0.49 -0.30 0.28 -1.56 0.06 0.26 
Klf4 0.20 1.36 1.18 0.58 1.15 1.95 
CGCGCG -3.29 0.69 0.01 -2.76 3.14 3.45 
TATA-box -1.36 -1.98 -1.91 -1.41 -1.55 -2.60 
Sp-1 -0.71 1.55 1.13 0.52 2.27 2.82 
Dec1 - KCACGTGM 0.19 0.46 0.31 0.06 0.60 0.79 
 
Figure 3.5.  Sequence content analysis of differentially occupied regions.  Enrichment values are 
normalized using log2.  cont. = regions occupied by MyoD in both myoblasts and myocytes.  cont. ex. = 
same as cont., but with no overlap to myogenin occupancy.  MyoD ex. = regions occupied by MyoD but 
not by myogenin at 60h after withdrawal of serum.  Myog ex. = same as MyoD ex., but in reverse.  
Ratios that do not pass a statistical significance test (p > 0.01) are displayed in grey. 
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Figure 3.6a.  Region-gene associations, ordered by expression category of the gene.  This analysis counts 
the number of regions associated with each category of genes, so occasionally the same gene 
contributes more than one region to the count.  The region-centric approach attempts to detect biases 
towards a particular expression profile, if any.  
 
 
myocyte myoblast flat wobbly unexp. 
Myogenin 1,331 430 5,242 3,788 3,995 
MyoD cycling 441 351 2,364 1,876 1,609 
MyoD 24h 888 388 3,850 2,793 1,988 
MyoD 60h 1,357 522 5,297 4,231 4,400 
Fosl1 72 117 587 526 959 
Mef2 273 94 1,277 825 603 
CTCF cycling 949 826 6,381 4,667 8,380 
CTCF myocyte 795 519 4,584 3,216 5,237 
Usf1 cycling 164 209 1,673 1,218 1,252 
Usf1 60h 127 130 1,324 928 864 
 
Table 3.6b.  Absolute numbers of regions associated with genes in each expression category.  These 
numbers were used to generate Figure 3.6a.  
0% 20% 40% 60% 80% 100% 
Myogenin 
MyoD cycling 
MyoD 24h 
MyoD 60h 
Fosl1 
Mef2 
CTCF cycling 
CTCF myocyte 
Usf1 cycling 
Usf1 60h 
Length of segment corresponds to fraction of regions associated with that category 
Da
ta
se
t myocyte 
myoblast 
flat 
wobbly 
unexp. 
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Transcription factor cycling diff - 60h diff - 5d diff - 7d 
     MyoD 167.4 200.6 131.8 84.5 
Myogenin 15.4 911.5 545.1 346.8 
Mef2a 7.9 33.1 27.1 25.8 
Mef2b 0.0 0.0 0.0 1.4 
Mef2c 1.0 20.6 27.6 31.3 
Mef2d 22.3 58.2 70.7 98.8 
Myf5 6.9 5.5 6.1 6.1 
Mrf4 0.1 2.4 9.3 24.3 
Fosl1 94.2 9.2 9.3 7.1 
Fosl2 11.3 19.4 23.6 35.6 
Junb 82.1 61.5 33.2 58.6 
Jund 69.8 115.1 72.6 129.7 
CTCF 17.2 10.1 6.3 4.6 
Dec1 12.0 73.0 70.7 64.1 
E47/E12 64.4 33.2 27.4 35.8 
Tcf12 (HEB) 22.5 25.0 18.0 14.0 
Klf4 6.9 42.0 18.8 18.1 
Sp1 8.9 7.2 5.6 5.5 
RP58 2.2 14.2 10.9 9.0 
Zeb1 6.2 20.7 19.0 16.8 
 
Table 3.7.  mRNA levels for various relevant transcription factors.  Levels are given in RPKM, based on an 
RNASeq measurements taken at four time points.  The time points are:  cycling myoblasts (cycling), 
differentiating myocytes 60 hours after withdrawal of serum (diff - 60h), differentiating myocytes 5 days 
after withdrawal of serum (diff - 5d), and maturing myocytes 7 days after withdrawal of serum (diff - 
7d). 
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Motif MyoD cyc MyoD 24h MyoD 60h Myogenin Randomized 
CAGSTG 81.4% 89.6% 86.0% 87.0% 42.6% 
CAGCTG 66.0% 77.4% 69.5% 75.4% 21.8% 
CAGGTG 38.8% 47.5% 48.3% 45.0% 28.0% 
RRCAGSTG 69.9% 82.9% 74.7% 76.0% 20.0% 
RRCAGCTG 56.0% 68.3% 58.6% 63.9% 11.9% 
RRCAGGTG 23.9% 31.9% 31.1% 27.6% 9.5% 
CACGTG 6.7% 7.7% 9.0% 9.2% 5.2% 
AP-1 36.1% 16.8% 15.7% 15.1% 9.0% 
Mef2 (Tapscott) 20.2% 18.3% 17.0% 16.9% 33.0% 
Mef2 (lit) 1.0% 1.4% 1.4% 1.5% 1.3% 
Klf4 17.3% 23.3% 28.0% 29.1% 10.4% 
CTCF 1.9% 3.8% 6.6% 5.7% 1.5% 
Usf1 1.2% 1.2% 1.8% 1.7% 0.7% 
CGCGCG 0.7% 2.6% 7.2% 5.9% 0.7% 
TATA-box 14.9% 12.2% 11.0% 10.2% 32.8% 
Sp-1 10.6% 17.1% 24.8% 23.9% 6.4% 
 
Table 3.8a.  Motif coverage of MRF-occupied regions.  Coverage is defined as the percentage of the total 
number of regions that contain at least one copy of the motif.  Randomized regions are included as a 
representation of expected coverage - the set consists of approximately 101000 randomly selected 
regions, each 501 nucleotides long (matching the standardized length of ChIP regions).  They were 
filtered to eliminate repeats and unsequenced nucleotides, as well as telomeric/centromeric sequence.  
This table list coverages for all occupied regions obtained from the dataset denoted at the top of the 
column. 
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Motif Fosl1 Mef2 CTCF cyc CTCF myoc Usf1 cyc Usf1 60h Randomized 
CAGSTG 35.0% 66.9% 43.6% 47.5% 42.4% 44.7% 42.6% 
CAGCTG 22.0% 52.7% 21.2% 23.4% 26.5% 28.9% 21.8% 
CAGGTG 18.3% 38.5% 30.1% 32.8% 23.2% 23.8% 28.0% 
RRCAGSTG 17.0% 52.5% 21.3% 23.8% 21.5% 23.6% 20.0% 
RRCAGCTG 12.5% 42.4% 11.6% 13.1% 15.4% 17.5% 11.9% 
RRCAGGTG 5.7% 23.4% 11.5% 12.8% 7.7% 7.9% 9.5% 
CACGTG 5.1% 18.1% 5.6% 6.1% 53.8% 55.9% 5.2% 
AP-1 70.5% 14.7% 7.3% 7.5% 24.0% 20.1% 9.0% 
Mef2 (Tap.) 24.6% 22.5% 21.4% 20.7% 16.6% 15.8% 33.0% 
Mef2 (lit) 1.1% 3.8% 0.8% 0.7% 1.2% 1.1% 1.3% 
Klf4 10.1% 32.4% 14.3% 14.7% 26.9% 29.5% 10.4% 
CTCF 0.6% 7.0% 47.0% 50.2% 6.1% 7.0% 1.5% 
Usf1 0.8% 9.3% 0.8% 0.9% 30.3% 32.2% 0.7% 
CGCGCG 0.2% 14.2% 2.6% 2.3% 9.2% 10.8% 0.7% 
TATA-box 21.5% 12.1% 17.5% 15.7% 13.2% 12.4% 32.8% 
Sp-1 5.2% 37.0% 12.8% 13.3% 28.3% 32.4% 6.4% 
 
Table 3.8b.  Motif coverage of ChIPSeq defined regions of occupancy for non-MRF transcription factors.  
Coverage is defined as the percentage of the total number of regions that contain at least one copy of 
the motif.  Randomized regions are included as a representation of expected coverage - the set consists 
of approximately 101 thousand randomly selected regions, each 501 nucleotides long (matching the 
standardized length of ChIP regions).  They were filtered to eliminate repeats and unsequenced 
nucleotides, as well as telomeric/centromeric sequence.  This table list coverages for all occupied 
regions obtained from the dataset denoted at the top of the column.  CTCF cyc and Usf1 cyc = 
occupancy in cycling myoblasts.  CTCF myoc = CTCF-occupied regions in myocytes.  Usf1 60h = Usf1-
occupied regions 60 hours after withdrawal of serum. 
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Motif early late cont. cont. ex. MyoD ex. Myog ex. Randomized 
CAGSTG 59.8% 89.9% 88.5% 79.3% 76.2% 78.1% 42.6% 
CAGCTG 38.8% 80.6% 75.1% 58.8% 50.9% 67.7% 21.8% 
CAGGTG 31.7% 55.4% 41.9% 39.3% 46.6% 35.7% 28.0% 
RRCAGSTG 40.9% 84.8% 80.1% 66.6% 63.3% 62.6% 20.0% 
RRCAGCTG 27.4% 72.8% 66.3% 48.6% 40.4% 54.6% 11.9% 
RRCAGGTG 16.7% 38.4% 26.9% 24.8% 31.7% 18.1% 9.5% 
CACGTG 5.2% 7.0% 7.4% 4.5% 7.0% 7.9% 5.2% 
AP-1 52.3% 5.0% 28.7% 27.3% 16.7% 12.4% 9.0% 
Mef2 (half) 22.2% 19.1% 19.0% 23.3% 20.8% 15.8% 33.0% 
Mef2 (lit) 0.9% 1.6% 1.1% 0.5% 1.3% 1.6% 1.3% 
Mef2 (hybrid) 2.0% 1.7% 1.9% 1.4% 1.6% 2.0% 2.1% 
Klf4 10.3% 19.2% 21.7% 13.3% 18.1% 29.4% 10.4% 
CTCF 0.4% 1.9% 2.7% 1.4% 4.8% 6.3% 1.5% 
Usf1 0.7% 0.9% 1.2% 0.6% 1.1% 1.3% 0.7% 
CGCGCG 0.1% 0.6% 1.0% 0.2% 4.8% 6.4% 0.7% 
TATA-box 20.2% 13.1% 12.9% 19.0% 15.8% 9.2% 32.8% 
Sp-1 3.6% 11.5% 13.4% 6.3% 15.6% 26.0% 6.4% 
 
Table 3.8c.  Coverage of differential MyoD regions by select motifs.  Mef2 (lit) corresponds to the 
canonical Mef2 motif CTAWWWWTAG.  Early = sites occupied by MyoD in cycling myoblasts but not in 
differentiating myocytes; Late = opposite of early; Cont. (continuous) = sites occupied by MyoD in both 
cycling and differentiating C2C12s; Cont. ex. (continuous exclusive) = same as continuous, but without 
corresponding myogenin occupancy; MyoD ex. = regions occupied by MyoD in differentiating myocytes 
that do not have corresponding myogenin occupancy; Myog ex.  = same as MyoD ex., but for myogenin; 
Randomized = set of ~101,000 randomly generated regions. 
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Figure 3.9a.  Sequence content analysis of Mef2-occupied regions. 1 = regions occupied by Mef2 that do 
not have corresponding myogenin occupancy, 2 = regions occupied jointly by Mef2 and myogenin, Mef2 
= all Mef2 regions, Myog = all myogenin regions. 
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Mef2 1.74 1.81 2.00 3.53 5.44 5.39 3.74 2.42 2.06 1.66 
Mef2-Myog 2.90 2.63 2.73 4.66 6.51 6.47 4.88 3.43 2.81 2.43 
Mef2+Myog -0.84 0.75 1.16 1.16 3.45 3.41 1.33 0.75 1.16 0.75 
Myog 0.15 -0.10 0.19 0.58 -0.27 -0.15 0.19 0.24 0.70 0.10 
 
Figure 3.9b.  Positional distribution of Mef2-hybrid site 
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Mef2 0.55 0.55 0.55 2.14 2.49 3.18 1.87 0.29 -0.03 -2.03 
Mef2-Myog 0.86 0.86 0.28 1.60 1.60 2.74 1.60 0.86 -0.72 -0.72 
Mef2+Myog 0.30 0.30 0.71 2.41 2.88 3.41 2.03 -0.29 0.30 -6.64 
Myog -1.30 0.22 0.28 0.74 0.40 0.70 0.65 0.56 -0.30 -1.49 
 
Figure 3.9c.  Positional distribution of Mef2 canonical site CTAWWWWTAG 
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Mef2 0.88 1.10 1.64 2.37 3.77 3.84 2.36 1.37 0.83 0.76 
Mef2-Myog 0.37 -0.08 0.19 0.19 0.45 0.71 0.14 0.19 0.28 -0.13 
Mef2+Myog 1.14 1.56 2.16 2.98 4.45 4.52 2.98 1.83 1.11 1.16 
Myog 0.57 0.88 1.27 2.24 4.50 4.56 2.19 1.26 0.92 0.61 
 
Figure 3.9d.  Positional distribution of RRCAGSTG 
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Mef2 1.79 1.79 2.44 3.94 6.37 6.07 3.07 1.79 2.15 2.15 
Mef2-Myog 2.29 2.29 1.88 4.88 7.30 7.00 3.75 2.61 2.29 1.88 
Mef2+Myog 1.31 1.31 2.72 2.53 5.01 4.68 2.31 0.72 2.05 2.31 
Myog 0.71 1.17 1.41 1.76 1.92 2.62 1.76 1.30 0.41 1.17 
 
Figure 3.9e.  Positional distribution of the Usf1 motif CACGTGAC 
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Motif Mef2 1 2 Myog Randomized 
Mef2 (Tapscott) 22.5% 18.4% 25.2% 16.9% 33.0% 
Mef2 (lit) 3.8% 3.2% 4.3% 1.5% 1.3% 
Mef2 (hybrid) 17.1% 34.5% 5.4% 2.1% 2.1% 
RRCAGSTG 52.5% 18.4% 75.6% 76.0% 20.0% 
RRCAGCTG 42.4% 10.8% 63.7% 63.9% 11.9% 
RRCAGGTG 23.4% 8.9% 33.2% 27.6% 9.5% 
CACGTG 18.1% 25.5% 13.1% 9.2% 5.2% 
Usf1 9.3% 16.3% 4.5% 1.7% 0.7% 
 
Table 3.10.  Coverage of Mef2 data by selected motifs.  1 = Mef2-Myog regions, 2 = Mef2+Myog regions, 
Mef2 = all Mef2 regions, Myog = all myogenin regions. 
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TGAGTCA 0.81 1.35 2.49 3.88 5.17 5.12 4.15 2.57 1.35 0.85 
TGASTCACW 1.12 1.90 2.70 4.35 5.59 5.63 4.84 2.87 1.22 1.01 
 
Figure 3.11a.  Positional distribution of two alternative AP-1/Fosl1 recognition motifs. 
 
Motif Fosl1 Randomized 
 
# of occ. 
TGAGTCA 70.54% 8.97% 
 
2457 
TGASTCACW 35.47% 2.84% 
 
1096 
 
Table 3.11b.  Coverage and absolute incidence of two potential AP-1/Fosl1 recognition motifs.  Motif 
TGAGTCA was cited as a consensus binding cited by Cao 2010 and others.  Motif TGASTCACW was 
derived via MEME from regions preferentially occupied by MyoD in cycling myoblasts, but not 
differentiating myocytes.  # of occ. = number of instances of the motif present in the Fosl1 HC set of 
occupancy signals.  Fosl1 = coverage of Fosl1 HC regions by the motif.  Randomized = coverage of the 
randomized set of regions by the motif. 
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MyoD cyc Fosl1 
Fosl1-
MyoD 
MyoD-
Fosl1 
Fosl1+ 
MyoD Random 
Motif 
      CAGCTG 2.34 0.32 -0.96 2.46 1.48 0.29 
CACCTG 0.72 -0.52 -1.27 0.78 0.34 0.23 
CAGSTG 1.61 -0.11 -1.13 1.71 0.92 0.26 
RRCAGSTG 2.54 0.01 -1.84 2.68 1.39 0.27 
RRCAGCTG 2.95 0.30 -1.77 3.09 1.80 0.29 
RRCAGGTG 1.67 -0.55 -1.94 1.80 0.50 0.24 
CACGTG 0.51 0.14 -0.03 0.52 -0.10 0.15 
CATATG -0.80 -0.57 -0.56 -0.80 -0.44 -0.12 
CAAATG -0.42 -0.26 -0.28 -0.44 -0.24 0.05 
CAATTG -0.69 -0.72 -0.74 -0.67 -0.73 0.01 
CAGATG 0.42 0.20 -0.15 0.37 0.68 0.18 
CAAGTG 0.01 -0.13 -0.28 0.00 0.01 0.11 
CACATG -0.16 -0.25 -0.40 -0.18 0.09 -0.02 
CAACTG 0.20 -0.14 -0.41 0.20 0.15 0.12 
Meis 0.65 -0.07 -0.30 0.71 0.32 0.20 
AP-1 2.34 3.64 3.64 1.84 3.59 0.11 
Mef2 (half) -0.91 -0.63 -0.52 -0.92 -0.75 -0.07 
Mef2 (hybrid) 0.03 0.00 -0.03 0.04 0.45 0.13 
Runx 1.02 0.59 0.29 1.02 0.84 0.21 
RP58 0.40 0.20 -0.19 0.35 0.59 0.13 
CTCF 0.78 -0.94 -0.79 0.96 -1.42 0.46 
Mef2 (lit) -0.36 -0.21 -0.96 -0.32 -0.27 -0.01 
Klf4 0.99 0.07 -0.24 1.11 0.27 0.20 
CGCGCG 0.04 -1.54 -1.16 0.34 -1.21 -0.04 
TATA-box -1.71 -1.13 -0.97 -1.72 -1.56 -0.26 
Sp-1 1.21 -0.18 -0.26 1.37 -0.35 0.42 
Dec1 - KCACGTGM 0.29 0.13 -0.41 0.34 -0.19 0.13 
 
Figure 3.12.  Motif content analysis of Fosl1-occupied regions, and for regions of joint and separate 
occupancy by Fosl1 and MyoD in cycling C2C12s. 
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Figure 3.13.  Binding affinity assay between Mef2a, Mef2d and the hybrid site derived from motif 
analysis of Mef2a occupancy.  Mef2a:Mef2a homodimers do not bind either the canonical or the hybrid 
motifs.  Mef2a:Mef2d heterodimers and Mef2d:Mef2d homodimers are able to bind the canonical but 
not the hybrid motifs. (Gel shift #64) 
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Motif Usf1 
Usf1-
Myog 
Mef2-
Myog Mef2 Myog 
CAGCTG 0.79 0.11 0.42 2.14 2.55 
CACCTG -0.11 -0.32 -0.07 0.84 1.08 
CAGSTG 0.33 -0.12 0.16 1.52 1.86 
RRCAGSTG 0.58 -0.24 0.25 2.37 2.78 
RRCAGCTG 0.91 -0.10 0.25 2.68 3.16 
RRCAGGTG -0.07 -0.45 0.24 1.76 1.97 
CACGTG 3.74 3.57 2.81 2.22 1.02 
CATATG -1.61 -1.51 -1.57 -1.37 -1.34 
CAAATG -1.02 -0.95 -1.42 -0.82 -0.67 
CAATTG -0.90 -0.85 -1.15 -1.10 -1.16 
CAGATG -0.35 -0.43 -0.60 0.01 0.26 
CAAGTG -0.39 -0.40 -0.64 -0.14 0.11 
CACATG 0.30 0.33 -0.82 -0.22 -0.15 
CAACTG -0.43 -0.53 -0.49 0.13 0.29 
Meis 0.08 -0.07 -0.10 0.53 0.77 
AP-1 1.44 1.49 0.15 0.93 0.97 
Mef2 (half) -1.28 -1.24 -0.93 -0.72 -1.20 
Mef2 (hybrid) 1.35 1.42 4.81 3.76 0.19 
Runx 0.28 0.09 0.03 0.72 1.06 
RP58 -0.54 -0.49 -1.06 -0.42 -0.22 
CTCF 2.63 2.35 3.15 2.70 2.42 
Mef2 (lit) -0.32 -0.68 1.24 1.57 0.22 
Klf4 1.97 1.56 2.29 2.07 1.89 
Usf1 5.98 5.77 5.17 4.33 1.56 
CGCGCG 4.02 3.49 5.18 4.49 3.37 
TATA-box -2.03 -1.86 -2.37 -2.17 -2.36 
Sp-1 3.44 3.05 4.24 3.58 2.80 
Dec1 4.55 4.32 3.95 3.12 1.03 
 
Figure 3.14.  Sequence content analysis of the Usf1 occupancy map in differentiating myocytes (60h 
after withdrawal of serum).  Usf1-Myog = regions occupied by Usf1 but not by myogenin in 
differentiating myocytes (60 hr); Mef2-Myog = regions occupied by Mef2 but not by myogenin in 
differentiating myocytes (60 hr);  Usf1, Mef2, Myog = all HC regions of occupancy for Usf1, Mef2 and 
myogenin, respectively, in differentiating myocytes (60 hr).  Enrichment is given as log2 of (observed 
density) / (expected density), values that are not significantly different from background (p > 0.01) are 
displayed in grey, negative values represent depletion of the associated motif. 
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Expression Category 
# Open 
connections 
# Blocked 
connections 
% Total 
connections that 
are open 
Muscle down 502 433 53.7% 
Muscle up 2401 898 72.8% 
Flat expressed 3740 1765 67.9% 
Unexpressed 4964 2286 68.5% 
 
Table 3.15.  CTCF occupancy is more likely to occur between myogenin regions and TSSes of down-
regulated genes in differentiating myocytes.  A blocked connection is defined as one of the form 
myogenin -> CTCF -> TSS for forward-oriented reading frames or TSS <- CTCF <- myogenin for reverse-
oriented reading frames.  An open connection is defined as one where the no CTCF occupancy event 
exists between a myogenin region and its nearest gene.  There is no statistical difference in the 
likelihood of connections being open for flat expressed and unexpressed genes.  Muscle-up genes have 
the highest probability of having open connections (p < 0.01), muscle-down genes have the lowest 
probability of having open connections (p < 0.0001). 
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Chapter 4:  Competitive transcriptional regulation and its role in defining 
lineage-specific cis-regulatory activity. 
 
4.1  Introduction:  bHLH diversity and the problem of lineage specificity 
 
The family of CANNTG-binding bHLH transcription factors is large, with over 600 proteins catalogued in a 
recent phylogenetic survey (Stevens et al. 2008), and its members perform a wide range of functions.  
Leucine-zipper bHLHs, named for the presence of a leucine-rich protein-protein interaction domain, 
serve a number of roles in cycling cells, with myc garnering significant attention due to its oncogenic 
properties (Bretones et al. 2014).  Usf1, also a bHLH-lz, is a "housekeeping" transcription factor active in 
both cycling and terminally differentiated cells - it maintains expression of genes that are necessary for 
cell function but not differentially transcribed in a lineage-specific manner (discussed in section 3.6).  
Members of the bHLH-orange family, such as Dec1 (also known Stra13 and bHLHb2) and Dec2 (also 
known as Sharp1) are transcriptional repressors (Shen et al. 2002; Honma et al. 2002), and are up-
regulated in multiple cell types during terminal differentiation.  They likely serve in an anti-proliferative 
capacity in a broad range of lineages, and together with bHLH-lzs form the basis for the model I will 
discuss in section 4.5.  Other bHLH proteins are crucial to cell fate determination - MRFs (MyoD, Myf5, 
Mrf4, myogenin) control skeletal myogenesis; NeuroD and neurogenin regulate neuronal development; 
E2A gene products - the two splice isoforms E12 and E47 have different bHLH domains - are important 
for B and T cell differentiation as homodimers, in addition to being crucial heterodimerization partners 
for many tissue-specific bHLHs; Tal1 (also known as Scl) directs terminal erythroid cell formation.  
Curiously, all of the lineage-directing factors just mentioned recognize and bind the same hexamer motif 
CAGCTG (Cao et al. 2010; Fong et al. 2012; Lin et al. 2010; Kassouf et al. 2010), and the E2A proteins are 
expressed alongside them.  How, then, is lineage specificity maintained in the presence of E2A, which 
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recognizes the same CAGSTG sites as the MRFs it heterodimerizes with, and can contribute critically 
towards inducing its own differentiation program? 
The answer, as it does for many things in mammalian biology, rests in a combination of mechanism.  The 
analysis and data in this chapter point to several ways in which superficially similar transcription factors 
establish and maintain lineage specificity. First, and perhaps simplest, binding affinities for specific 
subsets of likely recognition motifs can help us to understand the targeting of bHLH dimers, and in 
section 4.2 I examine in vitro affinities of MRFs and E proteins for variations of the e-box sequence at 
both central and flanking nucleotides.  The resulting sequence preferences are not sufficient to fully 
account for lineage specificity once I compare the occupancy map for E47 in differentiating B-cells (Lin et 
al. 2010) with my occupancy maps of MyoD and myogenin in differentiating myocytes (section 4.3).  
Many sites are occupied in both systems, and binding affinity alone neither accounts for exclusion of E:E 
homodimers from occupying CAGSTG motifs accessible in differentiating muscle, nor precludes MRFs 
from occupying some of the E:E specific sites.  Instead, the comparison of underlying sequence structure 
points to a cohort of co-expressed transcription factors that are all able to bind identical or very similar 
recognition sites, suggesting a competitive regulatory system.  I capture these interactions in a model 
that helps further account for lineage-specific occupancy, although it too does not fully explain it 
(section 4.4).  To address the likely prevalence and physiological importance of competitive systems, I 
introduce a second set of factors that, based on sequence analysis and current knowledge, are likely to 
behave in a similar fashion, with multiple co-expressed TFs competing for the same sets of target DNA 
elements.  Finally, I identify some specific examples in the genome worthy of functional testing to verify 
parts of the model (section 4.5).  This analysis and model are discussed in the context of transcriptional 
regulation, which is only one of several known ways of achieving lineage specificity.  Others include 
epigenetic silencing via chromatin compaction and DNA methylation, post-transcriptional regulation via 
non-coding RNAs, or post-translational factor modifications, to name a few.  It is the totality of these 
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inputs that drives developmental pathways.  In the scope of direct transcriptional regulation, 
competitive factor binding plays an important role in both cell fate determination and in the execution 
of the differentiation program. 
  
91 
 
4.2  Binding affinities of myogenin and E47. 
 
Sequence content analysis of myogenin-occupied regions showed that 75% of CAGSTG motifs contained 
therein had an RR prefix - a much higher than expected rate (p < 0.01).  While this enrichment was 
substantial and significant, it does not by itself preclude other prefixes from forming viable binding sites, 
although they are likely to be of lower affinity.  Additionally, when the RRCAGSTG motif components 
were analyzed separately based on central nucleotides, RRCAGCTG was observed ~3 times more 
frequently than RRCAGGTG in regions of myogenin occupancy.  Interestingly, the GC:GG ratio was lower 
in the subset of MyoD regions that were continuously occupied in both myoblasts and myocytes, and 
did not have an overlapping myogenin signal, although it remained >  1 in every subset of MyoD regions.  
Fong et al. (2012) reported that MyoD has a high affinity for the CAGGTG motif.  One hypothesis was 
that MyoD:E47 favors CAGGTG, while Myogenin:E47 favors CAGCTG.  An alternative hypothesis is that 
E47:E47 homodimers might have higher affinity for CAGCTG sequences due to their palindromic nature 
and the symmetric nature of homodimer.  To quantify the influence of central and flanking nucleotides 
on binding affinity of bHLH dimers, a series of binding assays were performed using 32P-labeled double-
stranded oligonucleotide probes and transcription factors synthesized in vitro using a coupled rabbit 
reticulocyte lysate expression system (see Methods). 
E47:E47 homodimers bind both RRCAGCTG and RRCAGGTG, with a slight preference for CAGGTG, and 
showed no detectable affinity for the scrambled e-box sequence used as a negative control.  
Unexpectedly, they also bound the myc-class e-boxes RRCACGTG (Figure 4.1).  Further examination 
using a panel of 32P labeled oligonucleotides standardized for specific activity revealed a preference for 
CAGGTG over CAGCTG, regardless of prefix, although both showed detectable binding.  Some 
interaction was observed with every probe except CTCAGCTG (Figure 4.2).  For E47:E47 homodimers 
binding affinity is influenced primarily by central nucleotides, with the prefix playing a lesser role.  
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Additionally, E47:E47 binds the myc-class e-box CACGTG in vitro, expanding its consensus to CASSTG.  
No interaction was observed between E47:E47 homodimers and CATATG e-boxes associated with Twist, 
nor any e-box of the type CAWWTG (data not shown - Gel shift #37).  Additionally, E47:E47 has a higher 
affinity for GG centered e-boxes rather than the GC-centered ones.  While this is counter-intuitive given 
the initial assumption about symmetry of homodimers and palindromic nature of CAGCTG, the same 
result was observed by Blackwell and Weintraub (1990) in their SELEX/SAAB experiments to determine 
MyoD and E2A binding preferences.  Their result for E47 remained somewhat speculative due to 
technical issues with the experiment, but my data confirm it.  A later effort to address the targeting and 
binding preferences of MyoD:E and Twist:E heterodimers (Kophengnavong et al. 2000) used only E12 as 
the heterodimerization partner, and since E12 does not homodimerize (Shirakata and Paterson 1995), 
no data for E:E homodimers was generated. 
Myogenin and MyoD were unable to bind MRF-class e-box sequences in the absence of E47 (Figure 4.3).  
Myog:E47 heterodimers efficiently interact with GACAGCTG and GACAGGTG, and, as expected, show 
very little affinity for GACACGTG myc-class e-boxes (Figure 4.1).  Lane 7 shows an E47:E47 complex 
interacting with GACACGTG, accompanied by an almost complete lack of a heterodimeric band.  An 
expanded competition panel was used to assess the effects of prefix and central nucleotides on 
E47:Myogenin affinity, which, in agreement with the in vivo site derivation, is highest for RRCAGSTG 
motifs, dropping off noticeably for RYCAGSTG and YRCAGSTG motifs, and similar to that of negative 
control for YYCAGSTG motifs (Figure 4.4).  These data are consistent with sequence content analysis, 
which confirms the strong preference for an RR prefix.  They do not, however, explain the heavy 
numeric bias towards RRCAGCTG motifs observed in myogenin-occupied regions in vivo, as the in vitro 
affinity indicates equal preference for GC and GG centered e-boxes.  Both Myog:E12 and MyoD:E12 
heterodimers can also bind MRF-class e-boxes, but with lower efficiency than corresponding 
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heterodimers involving E47 (Figure 4.5).  MyoD:E47 heterodimers show a slight preference for 
GACAGGTG over GACAGCTG (Figure 4.5), which is also consistent with expectation. 
The binding experiments show that simple site preference can explain some of the biased found through  
motif content analysis of MRF-occupied regions.  Myog:E47 and MyoD:E47 preferentially bind GS-
centered e-boxes with an RR prefix.  MyoD:E47 shows a slight preference towards the GG-centered 
motifs compared to GC-centered ones, while myogenin:E47 binds both equally.  This can be seen in two 
subsets of MyoD-occupied regions - those present only in cycling myoblasts ("early" MyoD) and those 
present in both myoblasts and myocytes, but without an overlapping myogenin occupancy event 
("continuous exclusive" regions) - both sets show a higher fraction of occupied RRCAGGTG motifs, 
although in both cases the ratio of GC:GG is still > 1.  Both of these groups of MyoD regions lack 
overlapping myogenin occupancy, and thus serve to illustrate the in vivo sequence bias of MyoD.  
E47:E47 homodimers showed three primary differences from the MRF:E hybrid species.  First, they do 
not have the RR prefix bias, accepting a much broader range of flanking nucleotides.  Second, they have 
a higher affinity for CAGGTG e-boxes compared to CAGCTG ones.  Finally, E47:E47 homodimers are able 
to bind to CACGTG e-boxes with comparable efficiency to that of CAGCTG.  In aggregate, these results 
do not explain the heavy bias towards GC-centered motifs observed in myogenin-occupied regions, but 
they do provide baseline expectations for an occupancy map comparison of Myog:E47 in differentiating 
muscle versus E47:E47 in differentiating B-cells. 
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4.3 Comparison of bHLH occupancy in differentiating skeletal muscle and B-cells. 
 
In addition to being a crucial partner for MyoD and myogenin's ability to bind DNA, the transcription 
factor E2A plays a key role in B-cell differentiation (Murre et al. 1991; Lin et al. 2010).  To better 
understand mechanisms used to enforce system-specific occupancy, data for E47:E47 homodimers in 
differentiating B-cells (Lin et al. 2010) were compared to MRF:E47 data in differentiating myocytes 
(C2C12).  To maintain consistency, raw reads were mapped to the mm9 genome assembly, then used as 
ERANGE input to identify 8103 HC regions occupied by E47.  They were compared to the 14786 HC 
regions occupied by myogenin in differentiating C2C12s 60h after withdrawal of serum, and to the 6641 
HC regions occupied by MyoD in cycling C2C12s.  MyoD 24 and 60 hr sets were also used in the 
comparison, but due to their high overlap discussed in section 3.2, their contribution to identifying 
system-specific occupancy proved minimal. 
The analysis focused on three sets of regions - those occupied in B-cells but not in muscle (4726), those 
occupied in muscle but not in B-cells (11212), and those occupied in both states (1842) (Figure 4.6a).  I 
should note that this analysis is likely to be more sensitive towards regions occupied in a B-cell specific 
manner, due to the almost twofold excess in the number of myogenin regions compared to the number 
of E47 regions.  It is difficult to say precisely how many sites "should" be occupied in a given setting, 
which makes attempts at normalization not well justified.  This, in turn, means that the stronger (or, 
more accurately, the larger) of the two determinations will contain a set of regions that, from a 
differential occupancy point of view, could all be false positives.  This problem is inherent to 
comparative ChIPSeq analysis, and is the limitation of current data.  The three sets of regions were 
analyzed for sequence content using the same combination of motif mapping and de novo searches as 
before.   
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Regions specific to B-cells exhibited noticeable differences in their sequence content.  The relative 
enrichment of RRCAGCTG and RRCAGGTG motifs compared to genomic background was virtually 
identical (Figure 4.6b), as opposed to the substantial preference for RRCAGCTG observed in muscle-
specific regions.  Furthermore, consistent with the in vitro results reported in 4.2, there was no bias in 
favor of RR-prefix bias, nor was there any bias against it (Figure 4.6c and d) - the enrichment of the 
octamers is solely the result of increased density of the core hexamers.  For muscle-specific occupancy 
by Myog:E, the non-RR versions of the CAGGTG motif occur at background levels, whereas the non-RR 
variants of CAGCTG were enriched regardless of prefix (as expected, those preceded by RR were the 
most heavily enriched) (Figure 4.6c).  This suggests that the RR prefix is of special importance to 
CAGGTG motifs in muscle-specific regions.  Part of the reason for this bias stems from the fact that 
E47:E47 has a higher affinity for CAGGTG than for CAGCTG, thus placing a higher premium on the use of 
the RR prefix to achieve muscle-specific occupancy.  Another likely reason for this bias is Zeb1, which will 
be discussed below. 
The motif for zinc finger repressor RP58 - CAGATGT (see Introduction) is significantly enriched in B-cell-
specific regions (p < 0.01) compared to genomic background, but depleted in their muscle counterparts 
(p < 0.01) (Figure 4.6B).  The canonical Mef2 motif and CGCGCG exhibited the opposite behavior (Figure 
4.6b), being significantly enriched in muscle-specific regions and depleted in B-cell-specific regions.   
The set of regions occupied in both B-cells and muscle had a motif content profile that is very similar to 
that of the muscle-specific regions, with the same preference for RRCAGSTG and a high ratio of GC:GG 
cores (central e-box nucleotides).  Their content for AP-1, Mef2 and CGCGCG was essentially the same as 
that of muscle-specific regions.  Taken at face value, this is consistent with the idea that modules shared 
between muscle and B-cells exhibit muscle-like characteristics indicative of MRF:E occupancy, in part 
due to the RR prefix requirement associated with the latter. 
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A blueprint emerges for the separation between muscle and B-cell networks.  On the sequence level, 
MRF-specific sites are distinguished by the presence of an RR prefix, and more loosely by the 
requirement that at least one of the two flanking nucleotides be an A or a G - Myog:E and MyoD:E 
dimers show little to no affinity for motifs of the form YYCAGSTG.  Conversely, E:E homodimers bind any 
sequence of the form CASSTG, although the CACGTG component is unique due to the presence of a CpG 
dinucleotide that serves as a methylation target.  CACGTG sequences occur less frequently in the mouse 
genome when compared to either CAGCTG or CAGGTG, with only ~250,000 instances, compared to ~1 
million for CACGTG and ~1.7 million for CAGGTG, before accounting for simple repeats (repeat masking 
reduces these numbers to 149K, 638K and 909K, respectively).  In addition to being a methylation target, 
CACGTG and its derivates also serve as binding sites for myc-family bHLHs, and consequently play an 
important role in cell cycle regulation.  In the B-cell-specific regions occupied by E47, CACGTG motifs 
occur twice as often as expected (p < 0.01), but their coverage is low (9.3%) compared to that of 
CAGSTG (89.4%), suggesting that E47:E47 occupancy is primarily achieved at the "myogenic" motifs 
CAGCTG and CAGGTG.  While CAGGTG is preferred in vitro, in vivo CAGCTG and CAGGTG are enriched at 
virtually the same level (Figure 4.6b) and both cover a majority of regions - 65.1% for CAGCTG, 71.8% for 
CAGGTG.  This behavior that suggests that both can, and do, serve as viable occupancy centers for E47 
homodimers. 
Sequence content alone does not fully capture lineage specificity.  Of special interest are motifs of the 
form RRCAGGTG, as both E47:E47 and MRF:E47 show a high affinity for them in vitro, and both MRFs 
and E2A proteins (E12/E47) are present in cycling and differentiating skeletal muscle cells.  A similar 
relationship was described between MyoD:E and NeuroD2:E (Fong et al. 2012), where both MyoD and 
NeuroD bind the motif RRCAGCTG, but NeuroD additionally binds RRACGATG, whereas MyoD 
additionally binds RRCAGGTG.  This led to dubbing GC-e-boxes "public" and GA/GG-e-boxes "private" in 
relation to the transcription factors studied (Figure 4.12).  However, in a physiological setting MyoD and 
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NeuroD are not expressed at the same time, and E:E homodimers show little in vitro affinity for 
CAGATG.  In differentiating skeletal muscle, however, both MRFs and E are present, and both have a 
high affinity for RRCAGGTG.  Some additional mechanisms are employed to enforce lineage specificity.  
One is chromatin silencing, which can be assessed by measuring the overlap between B-cell specific 
regions and repressive chromatin marks (such as H3K27me3) in differentiating muscle cells.  Another 
rests on relative availability of bHLH proteins present and their dimerization affinity.  Based on RNASeq 
data (Table 3.7), the myogenin message is present in almost thirtyfold excess compared to the E2A 
message in differentiating myocytes (at the 60 hr timepoint), although this ratio drops to ~10:1 by day 7.  
In cycling myoblasts Id1 and Id3 combined also exceed E2A by over tenfold at the RNA level.  It is likely 
that part of the reason for such high transcript abundance is to prevent formation of E:E homodimers 
through saturation - an effect primarily accomplished by Ids in cycling progenitors and by myogenin in 
terminally differentiating myocytes.  While the latter mechanism deserves further investigation, it is 
made all the more likely by the in vitro binding data, where a threefold molar excess of myogenin greatly 
diminished the band associated with E:E homodimers (Figure 4.4).  A further method for maintaining 
appropriate lineage-specific occupancy is proposed in sections 4.4 and 4.5. 
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4.4  Model:  RP58 and Zeb1 as attenuators in muscle CRMs. 
 
Recent work in astrocytes established that RP58 directly interacts with elements regulating the 
expression of Id1-4 (Hirai et al. 2012).  While the canonical binding site for RP58 is CAGATGT, it tolerates 
single nucleotide mismatches in certain positions, including the central one, and I noticed that several of 
the elements shown to interact with RP58 by Hirai et al. were of the form CAGCTGT.  This is supported 
by preliminary in vitro binding data, in which I observed that RP58 formed a band when presented with 
a 32P-labeled GACAGCTGTC oligonucleotide.  Because CAGCTG is palindromic, all ACAGCTG sequences 
must be accompanied by CAGCTGT on the opposite strand, making fully half of all RRCAGSTG motifs 
recognizable by both MRF:E47  and RP58.  The relationship is less straightforward for CAGGTG, since its 
not symmetric.  It is likely the this sequence is also acceptable for RP58, although further testing needs 
to be done.  If true, it would make all RRCAGGTGT also recognizable by MRF:E and RP58.  Furthermore, 
the primary RP58 motif - CAGATGT - is enriched in B-cell-specific occupancy regions (p < 0.01) and 
depleted in muscle-specific occupancy regions (p < 0.01) (Figure 4.6b).  Jointly, this suggests two 
functions for RP58 in myogenesis.  One is the direct repression of regions used in non-myogenic 
networks, the B-cell one amongst them.  While this is most likely accomplished through the optimal site 
CAGATGT, some qualifying CAGSTG sites could also be involved.  This repression most likely occurs in a 
"classic" manner - repressor binding to a recognition motif facilitates recruitment of co-repressors 
and/or histone deacetylases, leading to silencing of the target element.  The other is an attenuating 
effect exerted at accessible CAGSTG motifs.  Given the relative physiological concentrations of MRFs and 
RP58 present in differentiating myocytes, it is unlikely that RP58 can prevent occupancy of optimal MRF 
octamers (RRCAGSTG).  However, it should be able to delay occupancy and exert a titrating effect on 
sites recognized by both it and MRF:E heterodimers.  I expect the titration effect to be more pronounced 
at sites that are suboptimal for MRF:E, with the strongest attenuation achieved at sequences of the 
form YYCAGSTGT.  In fact, it is highly plausible that such sequences serve as repressive rather than 
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activating sites in a myogenic context, which is in sharp contrast to the "expected" role of a CAGGTG 
motif.  At the moment, both pathways represent working hypotheses.   
Consistent with the hypothesis, albeit not decisive, is the fact that 23% of B-cell specific E47 elements 
are covered by the RP58 motif (CAGATGT), although how often RP58 actually participates in the 
repression of those elements in skeletal muscle is unclear.  A direct measurement of RP58 occupancy by 
ChIPSeq would be highly desirable, but requires the availability of a strong ChIP-competent antibody, 
which is currently lacking.  Additionally, it is unclear how quickly RP58-meidated repression takes place -  
cases of efficient chromatin silencing followed by decoupling may prove challenging to capture via 
traditional occupancy measurements.  There is also evidence that a large subset of MRF motifs 
RRCAGSTG can be bound by RP58, leading to the attenuation hypothesis - though some of them could 
be completely repressed instead (which one can consider as the most severe form of attenuation).  A 
knockout of RP58 leads to deficiencies in hind limb myofiber development and immediate postnatal 
death due to absence of diaphragm function (Okado et al. 2009).  The underlying molecular basis for 
disruption in muscle development caused by the knockout merits a detailed investigation, with focus on 
possible de-repression and the set of genes that would be affected by it.  The impact of RP58 deficiency 
on genes expressed in B-cells could also be tested in a knockout. 
There is at least one other characterized zinc finger repressor that likely carries out an attenuating 
function in differentiating skeletal muscle, and could be involved in preventing MRF:E occupancy at B-
cell-specific sites.  Zeb1 binds CAGGTG e-boxes, and in C2C12 shows a similar expression pattern to 
RP58, although its transcript is present at a somewhat higher level (Table 3.7).  Recent results show that 
in the absence of Zeb1, expression of muscle-related genes proceeds at a greatly accelerated pace (Siles 
et al. 2013).  Zeb1 exerts an additional layer of control over the RRCAGGTG motif and its derivatives, for 
which both E:E and MRF:E have strong affinity.  Taken together, RP58 and Zeb1 help explain some of the 
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sequence content results described earlier.  In muscle-specific regions occupied by MRFs, there is a 
strong preference for the RR prefix - based on motif density analysis, I expect that virtually all functional 
motifs based around CAGGTG are of the RRCAGGTG form.  This takes advantage of the extra specificity 
of the MRF:E heterodimers, which require the prefix to bind efficiently, but are present in overwhelming 
abundance.  Motifs lacking the RR prefix are good targets for E:E homodimers, but the latter are unlikely 
to be present in significant physiological concentrations, due to large excess of Ids and/or MRFs 
(depending on the cell state).  Furthermore, such motifs are optimal targets for Zeb1, and any CAGGTG 
motif with a T suffix is also a target for RP58.  This mechanism, if true, helps account for the tight control 
over the availability of CAGGTG motifs on a sequence level.  The most "myogenic" motif - RRCAGGTG - is 
also the most tightly regulated one.  The expression patterns of both Zeb1 and RP58 (Table 3.7) also 
support them functioning in primarily attenuating roles during skeletal muscle differentiation, as both 
are up-regulated upon cell cycle exit, and neither transcript is particularly abundant in cycling myoblasts.  
Nevertheless, this does not preclude the possibility that both are important to myogenic fate 
determination through repression/attenuation of a few key sites early in the specification process.  
Interestingly, the RP58 promoter is strongly occupied by myogenin at 60 hr after differentiation.  The 
associated occupancy region contains two RRCAGSTG motifs, both highly conserved, and both viable 
RP58 targets.  While not conclusive, this raises the possibility of a feedback loop involving MRFs and 
RP58 that ultimately controls the expression levels of RP58.  And could the same mechanism be used in 
other tissue types where RP58 is expressed and CAGSTG-binding bHLH factors abound?  A further 
interesting problem to address would be to quantify the effects of over-expression of RP58 and Zeb1 in 
cycling myoblasts or in early progenitors prior to the expression of MyoD. 
The attenuation model is an example of "competitive regulation" - where an activating and a repressing 
factors both recognize the same DNA sequence, and are both present in the system (Figure 4.8).  This 
creates a site-specific equilibrium, with relative availability of competitors and their affinity for the 
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sequence in question determining the ultimate outcome.  It implies the ability to fine-tune the output of 
an active site through subtle sequence variation, where instead of destroying affinity for one of the 
regulators, relative affinities for a number of regulators are affected instead.  This allows for more 
complex and dynamic interactions than the "classic" model of transcription factors binding side-by-side, 
although the latter is clearly an important part of transcriptional regulation.  I believe that exploring and 
understanding competitive regulation will be vital to a refined understanding of not only myogenesis, 
but of every developmental pathway.  In addition to the MRFs - E2A - RP58 - Zeb1 system just discussed, 
in the next section I will provide another example of a potential competitive system at work in C2C12s. 
  
102 
 
4.5  Of mice and mycs:  An active in vivo network presents a model for studying competitive 
transcriptional regulation 
 
In the C2C12 muscle system, transcripts for Myc and its primary dimerization partner Max (Kato et al. 
1992) are present in both cycling and differentiating states (Table 4.7).  The former is expected for 
rapidly dividing cells, the latter can be explained in part by the role Myc plays in regulating 
mitochondrial biogenesis (Li et al. 2005).  Myc:Max heterodimers recognize and bind the e-box CACGTG 
(Krepelova et al. 2014), which in our discussion came up as an acceptable in vitro binding site for 
E47:E47 homodimers.  The latter are unlikely to be present in a sufficient physiological concentration to 
compete with Myc:Max (due to saturation by MRFs and Ids), but other bHLH transcription factors with 
known or possible motif overlaps are available.  Mad, Hes6, Dec1, Dec2, Usf1 and Usf2 all show 
substantial transcript levels throughout the differentiation process (Table 4.7), and are not reported to 
dimerize with either E47 of Ids.  They belong to two families of bHLH TFs - bHLH-lz (Myc, Max, Mad, 
Usf1, Usf2) and bHLH-orange (Hes6, Dec1, Dec2) (Dawson et al. 1995; Sun et al. 2007), with dimerization 
generally permissible among family members.  Their roles vary according to the species of dimer, some 
acting as transcriptional activators and others as transcriptional repressors.  All factors listed above bind 
motifs containing the core CACGTG (Figure 4.9), hence all compete for sections of the available 
population of CACGTG motifs.  While E47:E47 occupancy of CACGTG in muscle is unlikely to occur for 
other reasons (mainly lack of E47:E47), in B-cells a similar system could serve the additional role of 
controlling interaction between E:E and CACGTG.  Sequence content analysis of E47 regions of 
occupancy in B-cells supports this theory - while the in vitro affinity of E47 for CAGCTG and CACGTG is 
similar, in vivo occupancy favors CAGCTG, and the number of occupied CACGTG motifs is relatively small. 
The above analysis of motif preference and of the implied factor competition, synergy, or silencing at 
specific motif families provides a richer and more comprehensive starting framework for understanding 
in vivo transcription factor occupancy.  It is, however, only a starting point, since additional mechanisms, 
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both cis and trans, are likely at work.  On the sequence level, our analysis and other data show that 
there is some acceptable variation in most core e-box recognition sites for bHLH factors.  My analysis 
also shows that the influence of flanking nucleotides on binding affinity is important to understanding 
E:E vs. MRF:E occupancy in muscle and B-cells.  At the protein level, post-translational modifications 
(such as phosphorylation) and dimerization affinities play a significant role in the availability and activity 
of any particular species.  Nor is the provided list of TFs potentially interacting with CACGTG-based 
motifs exhaustive.  Nevertheless, this model serves as a starting point for representing a complex 
regulatory system, where multiple transcription factors could all potentially occupy the same DNA 
element.  The nature and strength of occupancy will be dictated by the overall availability of TFs 
themselves, their relative affinities for the target site in question, and cooperative effects (either direct 
or indirect through scaffolding proteins).  If properly understood, such a system allows for a highly fine-
tuned control of transcriptional output, directed both through subtle alterations of the base motif (often 
at the flanking rather than the core nucleotides) and variations in the amounts of competing TFs.  It also 
allows for a given CRM to function with a dynamic range of activity, instead of the simple on/off switch 
behavior usually associated with cis-regulatory elements.  More specifically, the bHLH-lz and bHLH-o 
system presented herein is important both to the proper maintenance of the cell cycle, and to the exit 
from it that accompanies terminal differentiation.  It is therefore likely to be involved in other 
developmental networks beyond myogenesis, and while not central to cell fate determination, it is 
important to the successful execution of the differentiation program. 
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4.6  Testing cis-repression in differentiating muscle 
 
Repressor elements have received less attention than positive acting elements in functional studies of 
muscle CRMs.  I would like to conclude by discussing a likely regulatory module that features several of 
the motifs highlighted during sequence content analysis of transcription factor occupancy in 
myogenesis.  The region in question is the promoter region of Atoh8, encompassing nucleotides 
between -600 bp and +0 bp from the RefSeq TSS (chr6:72,185,570 in the mm9 assembly). Atoh8 (atonal 
homologue 8) is itself bHLH transcription factor that has been implicated in the development of brain, 
pancreas and kidneys (Chen et al. 2011); it is expressed in cycling myoblasts, but the transcript levels 
drop twentyfold upon terminal myogenic differentiation (23.1 / 1.4 / 0.8 / 1.1 at cycling / 60hr / 5d / 7d, 
respectively).  Interestingly, its strongly up-regulated upon denervation (Berghella, unpublished).  
ChIPSeq data for MyoD and myogenin indicate that the neighborhood around Atoh8 contains several 
regions of high signal in both cycling and differentiating C2C12s (Figure 4.10).  The three sites outlined 
by blue boxes - one upstream, one in the first intron, and one downstream of the gene body - are only 
occupied by MyoD and myogenin in differentiating myocytes, when Atoh8 expression levels are 
minimal.  The site highlighted in yellow shows evidence of occupancy in both states. 
Several explanations for the apparent disparity between factor occupancy and transcriptional output are 
possible.  The first option, which I currently favor, arises from my analysis of motif content of the 
promoter adjacent region of Atoh8 (Figure 4.11) and the candidate distal elements.  Within the 
promoter region, I found and highlighted four motifs, three of which are associated with repressors 
present in the system - Dec1, KLf4 and RP58.  Furthermore, all three are up-regulated in differentiating 
myocytes and may explain the Atoh8 down-regulation in the face of MRF occupancy.   The 4th motif - an 
MRF-class octamer AACAGCTG - is also a viable target for RP58, and has no associated MRF signal.  I 
propose that one or more of Dec1, Klf4 or RP58 act to reduce the activity of the Atoh8 promoter, leading 
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to down-regulation of transcriptional output even in the presence of nearby MRF occupancy.  Two 
alternative possibilities should be mentioned for the sake of completeness.  One is that MRF-occupied 
sites proximal to Atoh8 do not have any interaction with the Atoh8 promoter, and instead either target 
other genes or accomplish nothing - if an area of chromatin is accessible and contains the correct 
binding site, MRF presence is likely even when it serves no regulatory function.  Another is that a 
myocyte-specific repressor site(s) exists that was not detected because the motif for the repressor in 
question was not included in sequence analysis, and because occupancy data for it are not available.  
This repressor would then act independently of the proposed promoter elements to reduce 
transcriptional output of Atoh8.   
The idea of repression mediated by the sites found in the promoter proximal region of Atoh8 is testable, 
and I've designed and put in motion a series of experiments to do so.  The first stage is to verify that a 
large construct containing the distal elements and native promoter recapitulate the pattern observed 
for Atoh8.  Stage two is an element-by-element dissection of the locus, measuring activity of each distal 
element with a simple, standard heterologous basal test promoter (TK minimal).  The goal of stage two 
is to learn which elements have activity, and to measure it in both the myoblast and the myocyte 
settings.  Simultaneously, the activity of the Atoh8 proximal promoter region will be tested on its own, 
and with fusion to cis-elements with known functional activity, including a myoblast-specific enhancer, a 
myocyte-specific enhancer, and a constitutive enhancer.  Presently, DNA constructs are designed, but 
the experiments themselves have not been carried out.  While speculative, this region serves as a good 
candidate for functional testing and study of repressive effects.   
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Figures and Tables (chapter 4) 
 
 
Figure 4.1. Binding affinity assay using E47, Myogenin and 32P-labeled double-stranded oligonucleotide 
probe.  Both proteins were synthesized in vitro using a rabbit reticulocyte lystae expression system.  
Lanes 1-4 contain E47 only, lanes 5-8 contain E47 and myogenin in equimolar ratios.  Probes are:  
GACAGCTG (lanes 1 and 5), GACAGGTG (lanes 2 and 6), GACACGTG (lanes 3 and 7), GTCTAGAACG (lanes 
4 and 8).  (Gel shift #72) 
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Figure 4.2. Interaction between E47:E47 homodimers (all lanes) and a panel 32P labeled e-box 
sequences.  Probe intensity was standardized at 500K cpm per reaction.  Each lane contains E47 
synthesized in vitro.  Probes are:  GACAGCTG (1), GACAGGTG (2), GCCAGCTG (3), GCCAGGTG (4), 
CGCAGCTG (5), CGCAGGTG (6), CTCAGCTG (7), CTCAGGTG (8), GACACGTG (9), GTCTAGAA (10). (Gel shift 
#93) 
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Figure 4.3. Myogenin and MyoD do not bind RRCAGSTG in the absence of E47.  Proteins were: 
reticulocyte mixture incubated without plasmid template (lanes 1-3), myogenin (lanes 4-6), myogenin 
and E47 in equimolar concentrations (lanes 7-9), MyoD (lanes 10-12).  Oligonucleotide probes were:  
GACAGCTG (lanes 1, 4, 7, 10), GACAGGTG (lanes 2, 5, 8, 11), GTCTAGAACG (lanes 3, 6, 9, 12). (Gel shift 
#89). 
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Figure 4.4.  Competitive binding assay using E47 only (lane 1) and E47:Myog mixture at a 1:3 molar ratio 
(lanes 2-10).  32P-labeled probe GACAGGTG at a 0.34 µM concentration was used in all lanes (1-10).  
Unlabeled competitor probes were added to lanes 3-10 at a 3.4 µM concentration (10x molar excess).  
Competitors are:  GACAGCTG (3), GACAGGTG (4), GCCAGCTG (5), GCCAGGTG (6), CGCAGCTG (7), 
CTCAGCTG (8), CTCAGGTG (9), GTCTAGAA (10). (Gel shift #103) 
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Figure 4.5.  Both MyoD:E12 and Myogenin:E12 formed in vitro from a linked transcription system bind 
MRF-class e-boxes in a manner similar to MyoD:E47 and Myogenin:E47.  Oligonucleotide probes were:  
GACAGCTG (lanes 1, 4, 7, 10), GACAGGTG (lanes 2, 5, 8, 11), GTCTAGAACG (lanes 3, 6, 9, 12). (Gel shift 
#90) 
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RRCAGCTG 3.08 2.11
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AP-1 1.00 0.11
RP58 -0.34 1.34
Mef2 (reference) 0.22 -1.12
Usf1 1.41 0.68
RYCAGCTG 2.09 2.23
RYCAGGTG 0.38 2.11
YRCAGCTG 2.22 2.73
YRCAGGTG 0.17 2.48
YYCAGCTG 1.79 2.21
YYCAGGTG -0.11 1.92
CGCGCG 3.23 1.37
TATA-box -2.27 -2.84
Sp-1 2.61 1.56
Dec1 0.89 0.69
 
Figure 4.6.   
A) Overlap between regions occupied by E47:E47 homodimers in differentiating B-cells (blue) and 
Myog:E47 heterodimers in differentiating muscle cells (red). 
B) Motif content analysis of B-cell-specific (B-cell) and muscle-specific (muscle) regions of occupancy.   
C) CAGCTG motifs preferentially contain the RR prefix in muscle-specific regions but not in B-cell specific 
regions. 
D) CAGGTG motifs preferentially contain the RR prefix in muscle-specific regions but not in B-cell specific 
regions.  Note that CAGGTG motifs without the RR-prefix occur at background levels in muscle-specific 
regions 
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Transcription factor cycling diff - 60h diff - 5d diff - 7d 
Myc 25.3 20.5 12.4 13.0 
Mycl1 7.9 5.7 4.3 3.9 
Max 30.1 16.9 12.0 12.5 
Mad 33.9 21.0 17.5 13.1 
Hes6 55.4 134.4 107.3 68.3 
Dec1 12.0 73.0 70.7 64.1 
Dec2 4.3 14.4 12.8 16.7 
Usf1 26.7 28.9 26.3 28.4 
Usf2 40.0 39.3 32.7 39.8 
 
Table 4.7.  mRNA levels of several CACGTG-binding bHLH transcription factors in cycling and 
differentiating C2C12s, based on RNASeq measurements.  Units of expression are FPKM (fragments over 
kilobase of RNA per million reads)  
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Figure 4.8.  Comparison between two modes of transcriptional regulation involving the same set of TFs.  
In the "neighboring" (or classic) case, each TF has its own binding site within the module, and joint 
occupancy leads to the desired output (be it repressive, activating, or insulating).  In the "competitive" 
case, both factors compete for the same sequence, and the output of the module depends on the 
current equilibrium conditions achieved through physiological availability of competing TFs and their 
respective affinities for the target site (as well as any secondary interactions that might be involved).  
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Figure 4.9  Various bHLH-lz and bHLH-o TFs present in C2C12s recognize common sets of DNA elements, 
but exert contradictory influences on transcriptional output from the linked TSS. 
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Figure 4.10.  MRF-occupied elements around the Atoh8 gene.  Elements highlighted in blue are only 
occupied by MyoD and myogenin in differentiating myocytes.  The element in gold is continuously 
occupied, showing a MyoD signature in cycling myoblasts and both MyoD and myogenin signatures in 
differentiating myocytes.  The element in green is preferentially occupied in cycling myoblasts - while it 
registers a MyoD signal at 24 hours after differentiation, it lacks any myogenin occupancy at 60 hrs.  The 
red arrow denotes the direction of the Atoh8 gene model relative to the diagram. 
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Figure 4.11.  Potential regulatory motifs in the Atoh8 promoter.  The e-box motif immediately upstream 
of the TSS is of the form AACAGCTG, with the reverse compliment CAGCTGTT.  This makes it both an 
MRF:E and an RP58 binding site.  The CACGTG e-box to the right of it is a possible Dec1/Dec2 interaction 
site, although this interaction is purely hypothetical.  Also present are recognition sites for Klf4 and RP58 
(the latter being a cited optimal site CAGATGT).  Both are repressors, and both are up-regulated in 
differentiating myocytes. 
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Figure 4.12.  Public and private e-boxes in myogenic vs. neurogenic lineages (based on Fong et al. 2012) 
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Chapter 5:  Conclusions 
 
I would like to conclude the presentation of my thesis results with a few summary remarks, and discuss 
the major question raised by my work, potential approaches the answering them, and their implication 
to the study of transcriptional regulation in skeletal muscle specifically and in development generally.  
To begin with, an interesting result arose from the analysis of the genome-wide occupancy map of 
myogenin - a highly differentiation-specific transcription factor was found associating with genes whose 
main distinguishing characteristic is that they are expressed, without regard for the actual expression 
trajectory.  It immediately leads to two questions that merit further consideration.  First - is there a need 
for a better method of associating TF-occupied elements with candidate regulatory targets; and second - 
is myogenin occupancy causal of transcriptional output, or merely coincidental with it? 
The first question is, in a sense, rhetorical - association based on chromosomal proximity is unbiased, 
but represents a "best guess" scenario.  Ideally, a method utilizing evidence of physical interaction 
between a regulatory element and its target promoter(s) should be used to make region-gene 
assignments.  Obtaining such a measurement is by no means trivial, and method for doing so has only 
recently become available (Fisher-Aylor, unpublished).  It provides a clear path for moving forward, with 
an opportunity to refine target associations, and data gathering/analysis are currently underway to 
address the larger question of 3D interactions between cis-regulatory elements and actively transcribed 
genes.  Such a map will increase the veracity of the list of genes affected by myogenin, and will lead to a 
better understanding of muscle-specific transcriptional activation.  However, it is unlikely to change the 
overarching  conclusion that myogenin-occupied regions preferentially associate with genes expressed 
in differentiating skeletal muscle, with myocyte-specific genes making up an important but relatively 
minor (no more than 10%) fraction thereof. 
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The second question poses an interpretation dilemma.  The preponderance of myogenin occupancy 
associating proximally with expressed genes can be explained in two ways.  One is that myogenin, as a 
positive-acting transcription factor, occupies cis-elements around genes that need to be expressed in 
differentiating muscle (including those that are not differentiation-specific), and contributes to their 
expression.  The somewhat more pessimistic explanation is  that chromatin in the area of an expressed 
gene is more likely to be accessible, in turn increasing the likelihood of making a myogenin binding site 
available.  Under this model myogenin will occupy any binding site that is not being obstructed by a 
competitor or actively repressed, but will have little to no influence on nearby gene expression, except 
at a relatively small (less than 10% of total occupied elements, limited to differentiation-specific genes) 
fraction of sites.  In truth, both explanations are almost certainly valid.  Based on its expression pattern, 
loss of function phenotype, and extensive mutagenesis analysis of select CRMs, it is clear that myogenin 
is crucial to the expression of muscle-specific genes and proper progress of terminal differentiation.  It is 
also very likely that myogenin, especially due to its high abundance, can occupy most elements in the 
genome that are presented to it unobstructed and meet the criteria for occupancy, such as having an 
RRCAGSTG recognition site, or perhaps more sophisticated combinations of targeting motifs.  The 
fundamental question, therefore, is how much does myogenin really contribute to the expression of 
genes that are not differentiation-specific? 
A way to begin evaluating this is through functional testing, where select elements are attached to a 
reporter construct, transfected into a skeletal muscle system, and construct activity measured under 
conditions of differentiation.  A number of such experiments were performed by a colleague - Gilberto 
DeSalvo, and one of them I will mention specifically.  Elements from two groups were selected and 
evaluated based on their ability to activate a reporter construct in differentiating C2C12 myocytes.  
Group 1 consisted of elements associated with genes expressed in myocytes, regardless of their 
expression trajectory over the course of differentiation or absolute mRNA abundance (so long as the 
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latter was statistically significant based on the RNASeq measurement).  Group 2 consisted of elements 
associated with genes lacking detectable (by RNASeq) transcript levels in myocytes.  Elements in group 1 
were more likely to activate a reporter construct, with p < 0.01.  While on its own not definitive, this 
strongly suggests that at least a number of non differentiation-specific genes are being regulated by 
myogenin in differentiating skeletal muscle. 
This raises a larger evolutionary question that extends beyond the muscle system.  It is reasonable and 
likely to assume that in other tissue types the predominant bHLH factor, if there is one, will have a large 
repertoire of accessible binding sites, and therefore exert influence over a large fraction of expressed 
genes.  In the case of skeletal muscle, nearly one third of the ~ 15,000 expressed genes have an 
associated myogenin-occupied CRM.  NeuroD2 and E47 occupancy studies in neurons and B-cells, 
respectively, tell a similar tale, albeit with varying percentages.  But in all three cases the number of 
"differentiation-indifferent" targets greatly outweighs the number of differentiation-specific ones.  
What, then, imparts tissue specificity?  Regulatory elements containing the motif RRCAGCTG are 
"suitable" to a number of bHLH TFs, and the presence of such an element would lead to the expression 
of the target gene in a variety of tissues.  Perhaps such generic CRMs form the core of the overall 
regulatory network, where more precise control over expression levels has evolved over time through a 
number of mechanisms, such as targeted epigenetic modifications, tissue-specific repression (perhaps at 
a CRM altogether), or competitive binding, where multiple species of TFs can recognize and bind the 
same motif.  It implies that a fairly large number of genes would have SOME level of expression in a 
variety of tissues - a hypothesis is at least superficially supported by the currently available RNASeq 
data.  A more in-depth analysis of the prevalence and use of such cross-tissue elements through a 
combination of ChIPSeq, RNASeq, and DNAse-hypersensitivity measurements would be invaluable to the 
overall understanding of transcriptional regulation in mammalian development. 
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Two similar results emerged from the cross-factor occupancy comparisons, both providing clues about a 
different aspect of transcriptional regulation.  It has long been known that at a number of well-studied 
elements several TFs contribute to the overall transcriptional output, such as the example of the 
"classic" muscle CRM involving joint occupancy/binding by Mef2 and MRF:E.  It is therefore believed that 
CRM diversity is at least partially achieved through the combinatoric use of recognition motifs, allowing 
for an extremely diverse range of "recipes" to be implemented through joint occupancy and/or 
repression.  While this model certainly remains true, both the Mef2 and early MyoD occupancy data 
point to an alternative mechanism that is also prevalent, where recruitment of a co-factor is 
accomplished primarily through protein-protein interactions, rather than joint DNA binding.  The 
immediate question - what makes those elements "special" - does not have a simple answer, at least on 
the level of underlying sequence.  Detailed analysis of 1323 regions jointly occupied by myogenin and 
Mef2 and containing only an RRCAGSTG motif without an accompanying CTAWWWWTAG failed to 
reveal a secondary motif that would help account for Mef2 occupancy.  While ChIPSeq data point to the 
presence of Mef2 at these elements, from a motif content standpoint there is no basis for it being there.  
Once again, a number of explanations are plausible.  The most straightforward one is that Mef2 is being 
recruited to these sites, either by interacting directly with myogenin:E (as suggested by Molkentin et al. 
1995), or by means of another part of the complex, such as p300/pCaf.  But the question remains as to 
what distinguishes these ~ 1,300 sites from the remaining ~ 11,000 sites that have myogenin occupancy 
and an underlying RRCAGSTG motif, but no joint Mef2 presence.  A more involved explanation is that 
Mef2 is recruited via protein-protein association, but only at elements where 3D interactions with other 
CRMs permit it.  Under this model looking for distinguishing sequence characteristics that separate co-
occupied elements would be futile, as there is no reason for them to be present in the first place.  
Instead, groups of connected elements would have to be considered as a whole, with specificity 
encoded either in the joint sequence content or the spatial arrangement of the resulting super-complex.  
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A priori it is difficult, if not impossible, to predict how such CRMs would be grouped - only through 
physical observation and study of long-range interactions can this model be evaluated.  It further 
emphasizes the need for refining techniques such as ChIA-PET, and is an exciting problem to study not 
just in relation to myogenin and Mef2, but as general question in the control of gene expression.  While 
transcriptional activity is regulated by complexes of collaborating TFs and co-factors, not all TFs with the 
ability to bind DNA that are present in a complex need to be encoded for in any given CRM. 
Finally, I would like to emphasize the importance of understanding binding affinities and their 
implications for transcriptional regulation and competitive occupancy.  Cohorts of factors that recognize 
variants of the same core site are present at various levels in both myoblasts and myocytes.  
Undoubtedly, similar groups exist in other cell types.  The bHLH family is large and diverse, and although 
various members have diverged to recognize different versions of the e-box motif (both with regard to 
the two interior nucleotides and the flanking sequence), much overlap still exists.  The information 
encoded in the motif provides a gradient of affinities for a variety of DNA-binding factors, which are 
present at different concentrations and in different combinations depending on the cell type or state.  
Additionally, non bHLH TFs and zinc-finger repressors can often recognize essentially the same sites.  
Understanding affinities and relative concentrations of potential binders can help us better evaluate the 
likely effect of a given CRM on gene expression.  For example, not long ago we might have considered 
the motif CTCAGGTGT to be a likely activating element in the skeletal muscle system - superficially it 
matches the CAGSTG primary binding site associated with MRF:E heterodimers.  However, I have now 
shown that such a motif is most likely to have a repressive function in skeletal muscle, if it has one at all.  
The YY "prefix" makes it an unfavorable target for MRF:E heterodimers, while the GG center and T suffix 
make it an optimal recognition site for Zeb1 and a likely recognition site for RP58 - both repressors that 
are up-regulated in differentiating myocytes.  Understanding competitive binding systems is an 
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important, and as yet relatively little-studied question in the context of understanding dynamic 
regulation of transcriptional output. 
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Appendix:  Materials and Methods 
 
Read mapping and peak calling 
Sequenced reads were mapped to the mm9 genome assembly using Eland originally and Bowtie after 
2009.  Initial Eland mapping were re-done using Bowtie to maintain consistency, which did not have a 
noticeable impact on the overall data analysis.  Peaks were mapped using the ERANGE algorithm 
(Mortazavi et al. 2007), which looks for areas with an over-representation of reads from the ChIP sample 
compared to the control sample (carried out with no antibody).  Absolute read numbers were 
normalized to reads per million (rpm) to allow for comparison of datasets with differing levels of 
sequencing depth.  For medium confidence (MC) region definition, a minimum read level of 3 rpm 
(reads per million) and 2x ratio of experimental/control reads was required.  For high confidence (HC) 
regions, a minimum read level of 5 rpm and a 4x ratio of experimental/control reads was required. 
Script library 
Extensive use was made of a collection of python scripts that I wrote.  They will be made available 
publically at http://woldlab.caltech.edu/~akirilus/ChIPSeq_utilities/ .  A user manual will be supplied for 
some of the more commonly used scripts. 
Association between regions of occupancy and genes 
In the absence of a direct measure of physical connectivity (such as ChIA-PET), proximity on the 
chromosome was deemed a rational and unbiased of associating occupancy events with candidate 
target genes.  A list of 31680 RefSeq models used for mapping of RNASeq data was used in conjunction, 
with a python script designed to perform a "closest neighbor" search between the list of TSSes and the 
list of occupancy peaks (either as determined by ERANGE, or taken as the midpoint of the occupied 
region for some of the very early data).  Initially association were restricted to a maximum distance of 
either 20K or 50K nucleotides, but analyses presented in this thesis all use unlimited range associations 
unless explicitly stated.  This assignment is performed by the script tag_regions_by_TSS_distance.py .  
Region length normalization 
Due to some variability in the individual lengths of called regions of occupancy, efforts were taken to 
normalize their length.  An unbiased method was to take either the computationally defined occupancy 
"peak" (nucleotide position corresponding to the highest ChIPSeq signal), or the midpoint of the region 
for some very early data that did not contain peak predictions, and extend it by a certain number of 
nucleotides on either side, referred to as "region radius".  Three sets of radii were considered 
extensively - 50 bp, 100 bp and 250 bp.  Most of the primary motif information could be captured using 
the 50 bp radius.  The 250 bp radius provided the greatest flexibility for locating collaborating motifs, 
but resulted in an overall dilution of the density of primary motifs (when taken over the whole of the 
region).  This was later corrected in motif density mapping, where each region would be split into 10 
"steps" of equal length (each 1/10th of the total length), and motif densities would be calculated per 
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cell.  The latter was made possible by the assumption that the computationally predicted peak 
correlates reasonably well with an actual occupancy event (which turns out to be true for most factors 
that were assayed).  Ultimately, the 250 bp radius was used for the analysis, meaning all standardized 
regions were of the same length - 501 nucleotides long (central nucleotide and 250 on either side).  A 
peak caller output file generated by ERANGE can be automatically length normalized to any desired 
radius using the utility convert_hts_to_radius-hts.py .   
Mapping of motifs in the mm9 genome 
To rapidly create motif location libraries, a C++ program was used that compare a supplied PWM to all 
motifs of the appropriate length, and reported all matches above a certain similarity threshold.  As 
inputs, the program required a PWM, a minimum similarity score required to generate a match, a list of 
all chromosome names in the genome to be considered, and appropriately named FASTA files for each 
chromosome (the latter contain the actual sequence).  The chromosome list allows for mapping to only 
select chromosomes, if desired.  Similarity score was computed through summation of fitness scores, 
where a fitness score corresponded to the likelihood of seeing a particular nucleotide at that position, as 
defined by the PWM.  The total score was then divided by the maximal score attainable for the PWM - if 
the ratio exceeded the pre-defined threshold, the location of the motif was reported, otherwise it was 
disregarded.  In general, for shorter sequences (8 nucleotides or fewer), a 100% match was required, 
while for longer and more degenerate sequences (such as the CTCF and NRSF motifs), this was relaxed 
to 80-85%.  Generation of libraries that included all locations for a given motif at a given stringency was 
desirable, as it allowed for rapid mapping of motifs to regions of ChIPSeq occupancy, and for additional 
filtration of motifs based on such criteria as conservation or overlap with simple repeats catalogued in 
the repeat masker database. 
Motif density calculations 
To compute motif density and the resulting enrichment/depletion relative to the background density in 
the genome at large, a stepwise process was used.  First, motifs were mapped to ChIPSeq regions, with 
the distance between center of the motif and center of the region used to identify its relative location 
(this number could be either positive or negative).  All mapped motifs were then "stacked" on top of 
each other, and each region split into 10 "steps" of equal length.  Note that the number of steps is 
flexible, and reducing it to 1 will simply return the overall density/enrichment measurement for regions 
as a whole.  Next, all motifs in a given step were summed across all regions, and that number divided by 
(size of step * number of regions in the list) to create a density measurement in motifs/nucleotide.  The 
resulting density was then divided by the total genome density of the motif, defined as (# of motifs in 
the genome / # of nucleotides in the genome).  This provided the relative enrichment or depletion value.  
Statistical significance was evaluated using a χ2 test for each "step", with a requirement of p < 0.01 in 
order for an enrichment or depletion to be considered significantly different from the background.  
Using too many steps in conjunction with a small enough input set of regions could render the output 
meaningless due to lack of statistical significance - this is reported through the associated χ2 calculation. 
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Motif mapping, motif density calculations, and χ2 values were computed in an automated pipeline 
available in the script library (batch_map_motifs.py and batch_analyze_regions.py).  As inputs these 
programs require a list of motifs to be mapped, a list of regions to which they will be mapped, and a pre-
generated locations library for each motif.  While mapping will be performed accurately on regions of 
any length, density calculations and associated significance tests can only be performed on regions of 
standardized length, due to the "stacking" requirement. 
Region overlap detection 
A script was written to detect overlap between regions in two occupancy maps (matching_regions3.py).  
It takes as input two occupancy maps and a threshold of similarity.  The regions in each determination 
need to be sorted in ascending coordinate order - this is done automatically if ERANGE output is being 
used.  Overlap between two regions is defined as (# of nucleotides in common / length of the smaller of 
the two regions).  Any pair of regions for which overlap ≥ threshold is reported.  Several ways of 
reporting overlapping regions exist, and 4 of them are available with this script (see manual).  In the 
analysis reported as a part of this thesis, 80% similarity thresholds were required to declare two 
occupancy events overlapping, unless otherwise stated.  Because region lengths were standardized, this 
means that they would have to share at least 401 out of 501 contiguous nucleotides. 
Repeat masking 
To reduce potential motif density biases introduced by simple repeats, total motif libraries were filtered 
prior to being mapped onto ChIPSeq regions.  The filter used as input a total motif library and a list of 
simple repeats (available from UCSC or repeatmasker), and returned a list of motifs that did not overlap 
any of the coordinates included in the repeats database.  The script is available as 
motif_repeat_masker_filter.py .  Note that doing so reduces both the total pool of motifs and the 
effective size of the genome - both were taken into account when computing relative and background 
densitites. 
Conservation of motifs 
In order to evaluate the relative conservation of a motif, placental mammals PhastCons data were used.  
Each nucleotide is given a conservation score by PhastCons, ranging from 0 (not conserved) to 1 
(completely conserved).  Several ways exist of computing a total conservation score for a motif, with the 
simplest being to sum up all scores for all base positions, divide it by length, and compare it to the 
desired threshold.  I chose to adopt a different method (dubbed "entropic" for the purpose of this 
discussion), which aimed to take advantage of binding affinities encoded by a PWM.  Instead of looking 
at the sum of conservation scores, each nucleotide is considered individually.  The threshold value 
(between 0 and 1) is multiplied by the normalized information content of that base as defined by the 
PWM (1 for a perfectly defined base, 0 for an N) to compute the adjusted threshold.  If the PhastCons 
score listed is ≥ adjusted threshold, the nucleotide passes, otherwise it fails.  If every nucleotide passes 
the threshold test, the motif is considered entropically conserved at that level.  Extensive testing 
pointed to 0.7 as a reasonable entropic conservation threshold to be used in the analysis. 
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Randomized region generation 
To provide an measure of how likely a motif is to occur in a population of 501-nucleotide long regions 
selected at large, a list of randomized regions was created.  Initially, the criteria was only set that the 
regions be 501 nucleotides long.  The resulting 500,000 regions were filtered for overlap with simple 
repeats (via repeatmasker) and for overlap with centromere/telomere regions of the chromosome to 
which they were assigned.  Any regions with overlap to either were discarded.  The winnowed set was 
then further filtered for sequencing quality, and any region containing unsequenced nucleotides (Ns) 
was also discarded.  The resulting set of ~101,300 regions was treated as a control set of ChIPSeq 
regions for evaluating central tendencies or enrichments of motifs (it was not used to compute density 
enrichment - total genomic density was used, as described previously).  No effort was made to remove 
coding sequence from the set of control regions because ChIPSeq regions at times overlap exons. 
Gel shift assays 
Mobility shift assays were performed in 20 µl volume using a final concentration of 25 µM HEPES, 1 µM 
DTT, 100 mM NaCl, 5 µM MgCl2, 5 µM EDTA, 5% glycerol by volume.  400 ng poly dI*dC was used in each 
reaction to inhibit non-specific binding.  Labeled probe, cold competitors and protein products were 
added as appropriate, with 0.15 - 0.4 pM of labeled probe used per reaction (based on emission 
standardization or the requirements of the reaction).  Emission intensity standardization was done using 
dry scintillation counting.  Reactions were incubated at room temperature for 2 - 3 hours, then run on  
8% Tris-Glycine non-denaturing gels. 
Oligonucleotide labeling and protein synthesis 
Oligonucleotide probes were labeled ordered as single-stranded complementary pairs.  The forward 
strand oligo was radioactively labeled using 32P γ-ATP from Perkin Elmer and a 5'-DNA labeling kit 
(polynucleotide kinase) from Promega.  After the labeling reaction, forward and reverse strand oligos 
were annealed by melting (95oC for 5 mins) and allowing to cool to room temperature.  NEB2 buffer was 
used as annealing buffer.  Transcription factor synthesis was performed in vitro using a rabbit 
reticulocyte coupled expression kit (Promega) with Sp6.  Non-linearized templates (as per the protocol 
provided with the kit) were used, with a total amount of input DNA in the range of 400-500 ng / 
reaction.  Protein synthesis was assessed by 35S labeling (Perkin Elmer) and running an aliquot of the 
reaction product on a 10% Bis-Tris denaturing gel.  Although a radioactive protein can be used in 
conjunction with cold (unlabeled) oligonucleotides to generate a "reverse labeled complex" (this was 
done at one point to correct technical issues), cold proteins were used in conjunction with labeled 
probes to generate the actual mobility shift data presented in chapter 4. 
ChIPSeq 
The protocol used for ChIPSeq, associated library building, and sequencing, is essentially the same as the 
one used by Mortazavi et al. (2007) and currently utilized by ENCODE. 
